California MCLE - Securities Purchase Agreement - Morgan Stanley and Best Investment Corp.

1.	Authorization and Sale of Securities. The Company is proposing to sell a stated amount of Securities determined as provided in Section 2.1 below.

2. Agreement to Sell and Purchase the Securities.

2.1.

Upon the terms and subject to the conditions hereinafter set forth, at the Closing (as defined in Section 3), the Company will sell to the Investor, and the Investor will purchase from the Company, at the Purchase Price, a stated amount of Securities calculated promptly after the Maximum Settlement Rate is determined (as contemplated in the Offering Memorandum) so that the Ownership Percentage for the Investor and China Investment Corporation (the “Guarantor”) as of the Closing Date will equal 9.90%. The term “Ownership Percentage” means a fraction (i) the numerator of which is the sum of (a) the Maximum Settlement Rate multiplied by the aggregate stated amount of Securities to be purchased by the Investor divided by $1,000 and (b) all other shares of Common Stock (including any shares of Common Stock underlying any securities convertible into or exchangeable for Common Stock) then held by the Investor and the Guarantor and any of their respective Controlled Affiliates, and (ii) the denominator of which is the sum of (c) the numerator (excluding any shares that are already outstanding and therefore covered by the following clause (d)) and (d) the total shares outstanding of the Company’s Common Stock on November 30, 2007.

Notwithstanding the foregoing, if on the Closing Date, the Investor and the Guarantor, and any of their respective Controlled Affiliates, directly or indirectly own any shares of Common Stock or any securities convertible into or exchangeable for Common Stock (any such shares or securities, “Other Securities”), then the Investor and the Guarantor shall take such actions necessary to reduce the amount of Other Securities directly or indirectly owned by the Investor, the Guarantor and their Controlled Affiliates on or before January 31, 2008, which date shall constitute an additional Closing Date hereunder on which the Investor shall purchase, and the Company shall sell, an additional amount of Securities at the aggregate Purchase Price therefor (plus accrued and unpaid contract adjustment payments and distributions on the trust preferred securities from the initial Closing Date), such that the Ownership Percentage for the Investor and the Guarantor as of that additional Closing Date is 9.9% and the Ownership Percentage Underlying The PEPS is at least 9.75%. The term “Ownership Percentage Underlying The PEPS” means a fraction (i) the numerator of which is the Maximum Settlement Rate multiplied by the aggregate stated amount of Securities to be purchased by the Investor divided by $1,000 and (ii) the denominator of which is the sum of the numerator and the total shares outstanding of the Company’s Common Stock on November 30, 2007 or such later date as the Company determines is practicable.

At the additional Closing Date as contemplated in the preceding paragraph, the condition referred to in Section 3.3(d) shall be deemed to read:

A-1

The representations and warranties of the Company contained in Sections 4.1, 4.2, 4.3, 4.8, 4.9, 4.10, 4.11, 4.12, 4.13, 4.14, 4.15, 4.16 of this Agreement shall be true and correct on and as of the date hereof and on and as of the Closing Date as if made on and as of the Closing Date, and the Investor shall have received a certificate of a senior officer of the Company, dated as of the Closing Date, certifying to that fact.

If any Securities are issued at any additional Closing Date, they shall after issuance be treated for purposes of the Stock Issuance Agreements and Transaction Agreements as though they had been issued at the initial Closing Date.

2.2.

The Company and the Investor agree for United States tax purposes (in the absence of an administrative pronouncement or judicial ruling to the contrary):

(i)

to treat the acquisition of a Security as an acquisition of the trust preferred security and the stock purchase contract constituting such Security;

(ii)

to allocate 100% of the purchase price of a Security to the trust preferred security;

(iii)

to treat the junior subordinated debentures as indebtedness of the Company for U.S. federal income tax purposes which is not subject to the contingent payment debt regulations; and

(iv)

to treat the Investor as the beneficial owner of (a) the junior subordinated debenture or applicable ownership interest in the treasury portfolio that is part of a Corporate Unit owned by the Investor or (b) the qualifying treasury security that is a part of a Treasury Unit owned by the Investor.

3. Closings and Delivery of Securities and Funds.

3.1

The completion of the purchase and sale of the Securities (the “Closing”) shall occur on December 28, 2007 (the “Closing Date”), or as soon thereafter as the conditions to Closing can be satisfied, at the offices of the Company’s counsel. At the Closing, (i) the Company shall cause the Stock Purchase Contract Agent to deliver to the Investor the stated amount of Securities computed as set forth in Section 2.1, and (ii) the Purchase Price for such Securities shall be delivered by or on behalf of the Investor to the Company.

3.2

Payment by the Investor for the Securities shall be made by wire transfer of immediately available funds to the Company and the Company shall instruct the Stock Purchase Contract Agent to release the corresponding Securities to the Investor.

3.3

The obligation of the Investor to pay the Purchase Price pursuant to this Agreement shall be subject to the performance by the Company of its obligations hereunder and to the following additional conditions:

The Investor shall have received an opinion, dated the Closing Date, of Davis Polk & Wardwell, counsel for the Company, substantially in the form set forth in Exhibit

A-2

A-1 to this Agreement, an opinion of Richards, Layton & Finger, substantially in the form set forth in Exhibit A-2 to this Agreement, and an opinion from internal counsel at the Company, in a form customary for transactions of this nature, to the effect that the transactions contemplated hereby do not contravene other agreements binding on the Company and its subsidiaries.

On the Closing Date, the Investor shall have received a registration rights agreement (the “Registration Rights Agreement”), including customary representations, warranties, covenants, black-outs and expense and indemnification provisions, relating to the resale of the Securities and any Common Stock issuable upon settlement of the Securities executed by the Company, in form and substance reasonably satisfactory to the Investor.

The shares of Common Stock issuable upon settlement of the Stock Purchase Contracts shall have been duly authorized for listing, subject to official notice of issuance, on the New York Stock Exchange.

The representations and warranties of the Company contained in this Agreement shall be true and correct on and as of the date hereof and on and as of the Closing Date as if made on and as of the Closing Date, and the Investor shall have received a certificate of a senior officer of the Company, dated as of the Closing Date, certifying to that fact.

Any approvals or authorizations of, filings and registrations with, and notifications to, all governmental or regulatory authorities (collectively, “Governmental Entities”) required for the Closing shall have been obtained or made and shall be in full force and effect and all waiting periods required by law shall have expired; and no provision of any applicable law or regulation and no judgment, injunction, order or decree shall prohibit the Closing, and no Governmental Entity shall have instituted an investigation or proceeding that could result in such a judgment, injunction, order or decree.

Insofar as the Offering Memorandum and the Term Sheet describe the Securities Issuance Agreements (as defined below), such agreements accurately reflect, in all material respects, such description and are, to the extent not so described, in form and substance reasonably satisfactory to the Investor.

3.4

The Company’s obligation to issue and sell Securities to the Investor shall be subject to the following conditions, any one or more of which may be waived by the Company: (a) the accuracy of the representations and warranties made by the Investor and the fulfillment of those undertakings of the Investor to be fulfilled prior to the Closing and (b) any approvals or authorizations of, filings and registrations with, and notifications to, all Governmental Entities required for the Closing shall have been obtained or made and shall be in full force and effect and all waiting periods required by law shall have expired; and no provision of any applicable law or regulation and no judgment, injunction, order or decree shall prohibit the Closing, and no Governmental Entity shall have instituted an investigation or proceeding that could result in such a judgment, injunction, order or decree.

A-3

3.5	The Investor shall remit by wire transfer the amount of funds equal to the Purchase Price for the Securities being purchased by such Investor to an account designated by the Company prior to the Closing Date.

4. Representations, Warranties and Covenants of the Company. The Company hereby represents and warrants to, and covenants with, the Investor, that, except as otherwise disclosed in the Company’s Annual Report on Form 10-K for the fiscal year ended November 30, 2006 or its other reports and forms filed with the Securities and Exchange Commission (the “Commission”) under Sections 12, 13, 14 or 15(d) of the Securities Exchange Act of 1934 (the “Exchange Act”) after November 30, 2006 (excluding disclosures of risks included in any forward-looking statement disclaimers or other statements that are similarly non-specific and are predictive and forward-looking in nature) (the “SEC Reports”) and before the date of this Agreement:

4.1

Organization, Authority and Significant Subsidiaries. The Company has been duly incorporated and is validly existing as a corporation in good standing under the laws of the State of Delaware, with corporate power and authority to own its properties and conduct its business as currently conducted, and, except as would not be reasonably likely to have a Material Adverse Effect, has been duly qualified as a foreign corporation for the transaction of business and is in good standing under the laws of each other jurisdiction in which it owns or leases properties, or conducts any business so as to require such qualification; each subsidiary of the Company that is a “significant subsidiary” within the meaning of Rule 1-01(w) of Regulation S-X under the Securities Act (individually a “Significant Subsidiary” and collectively the “Significant Subsidiaries”) has been duly organized and is validly existing in good standing under the laws of its jurisdiction of organization.

4.2

Capitalization. As of August 31, 2007: (1) the Company has 3,500,000,000 authorized shares of Common Stock; (2) the Company has 1,062,450,986 issued and outstanding shares of Common Stock; (3) all of the issued shares of capital stock of the Company have been duly and validly authorized and issued and are fully paid and non-assessable; and (4) all of the issued shares of capital stock of each Significant Subsidiary have been duly and validly authorized and issued, are fully paid and non-assessable, and are owned directly or indirectly by the Company, free and clear of all liens, encumbrances, equities or claims. As of November 30, 2007, the Company has 1,056,289,659 issued and outstanding shares of Common Stock.

4.3

Authorization, Enforceability of Securities Issuance Agreements and Transaction Documents. The Company has the power and authority to enter into the Securities Issuance Agreements and Transaction Documents and to carry out its obligations hereunder and thereunder. The execution, delivery and performance of the Securities Issuance Agreements and Transaction Documents by the Company and the consummation of the transactions contemplated hereby and thereby have been duly authorized by all necessary corporate action on the part of the Company.

As of the date of execution of the Securities Issuance Agreements and the Transaction Documents, as the case may be, neither the execution, delivery and performance by the Company hereof and thereof, nor the consummation of the transactions contemplated

A-4

hereby and thereby, nor compliance by the Company with any of the provisions thereof, will (1) violate, conflict with, or result in a breach of any provision of, or constitute a default (or an event which, with notice or lapse of time or both, would constitute a default) under, or result in the termination of, or accelerate the performance required by, or result in a right of termination or acceleration of, or result in the creation of, any lien, security interest, charge or encumbrance upon any of the properties or assets of the Company or any Significant Subsidiary under any of the terms, conditions or provisions of (A) its certificate of incorporation or by-laws or (B) any note, bond, mortgage, indenture, deed of trust, license, lease, agreement or other instrument or obligation to which the Company or any Significant Subsidiary is a party or by which it may be bound, or to which the Company or any Significant Subsidiary or any of the properties or assets of the Company or any Significant Subsidiary may be subject, or (C) subject to compliance with the statutes and regulations referred to in the next paragraph, violate any statute, rule or regulation or any judgment, ruling, order, writ, injunction or decree applicable to the Company or any Significant Subsidiary or any of their respective properties or assets except, in the case of clauses (B) and (C), for those occurrences that, individually or in the aggregate, could not reasonably be expected to result in a Material Adverse Effect.

Other than in connection or in compliance with the provisions of the Securities Act and the securities or blue sky laws of the various states, to the best knowledge of the Company, no notice to, filing with, exemption or review by, or authorization, consent or approval of, any Governmental Entity is necessary for the consummation of the transactions contemplated by the Transaction Documents.

As used herein, (a) the term “Securities Issuance Agreements” refers collectively to (i) the trust agreement that will govern the Trusts, (ii) the indentures, and supplements thereto, that will govern each series of the Company’s junior subordinated debt securities held by the Trusts, (iii) the junior subordinated debentures, (iv) the Stock Purchase Contracts pursuant to which the Company will sell the Common Stock to the Investor and (v) the purchase contract and pledge agreements pursuant to which the Trust Preferred Securities will be held as collateral in favor of the Company and (b) the term “Transaction Documents” refers collectively to this Agreement and the Registration Rights Agreement.

4.4

Company Financial Statements. The consolidated financial statements of the Company and its consolidated subsidiaries included or incorporated by reference in the SEC Reports present fairly in all material respects the consolidated financial position of the Company and its consolidated subsidiaries as of the dates indicated therein and the consolidated results of their operations for the periods specified therein; and except as stated therein, such financial statements were prepared in conformity with GAAP applied on a consistent basis (except as may be noted therein).

Deloitte & Touche LLP, who have certified certain financial statements of the Company and its subsidiaries, are independent public accountants as required by the Act and the rules and regulations of the Commission.

A-5

The Company and its subsidiaries do not have any liabilities or obligations (accrued, absolute, contingent or otherwise), other than liabilities or obligations (i) reflected on, reserved against, or disclosed in the notes to, the Company’s consolidated balance sheet included in the Company’s Quarterly Report on Form 10-Q for the fiscal quarter ended August 31, 2007, (ii) disclosed in the Company’s Current Reports on Form 8-K filed on November 8, 2007 and November 9, 2007 or in the press release and related financial supplement referred to in Section 17 below or (iii) that could not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.

4.5

No Material Adverse Effect. Since August 31, 2007 and except as described in the SEC Reports and the press release being issued on the date hereof as contemplated by Section 17 hereof, no event or circumstance has occurred that, individually or in the aggregate, has had or could reasonably be expected to have a Material Adverse Effect.

4.6

Proceedings. Except as disclosed in the SEC Reports, there are no litigation or similar proceedings pending or, to the Company’s knowledge, threatened to which the Company or any of its subsidiaries is a party or of which any property of the Company or any of its subsidiaries is the subject which, individually or in the aggregate, could reasonably be expected to have a Material Adverse Effect.

4.7

Compliance with Laws; Permits. The Company and each of its Significant Subsidiaries have conducted their businesses in compliance with all applicable federal, state and foreign laws, regulations and applicable stock exchange requirements, except where (i) the failure to be in compliance could not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect or (ii) the necessity of compliance, or the failure to comply, therewith is being contested in good faith by appropriate proceedings.

The Company and each of its Significant Subsidiaries have all permits, licenses, authorizations, orders and approvals of, and have made all filings, applications and registrations with, any Governmental Entities that are required in order to carry on their business as presently conducted, except where the failure to have such permits, licenses, authorizations, orders and approvals or the failure to make such filings, applications and registrations, individually or in the aggregate, could not reasonably be expected to have a Material Adverse Effect; and all such permits, licenses, certificates of authority, orders and approvals are in full force and effect and, to the knowledge of the Company, no suspension or cancellation of any of them is threatened, and all such filings, applications and registrations are current, except where such absence, suspension or cancellation, individually or in the aggregate, could not reasonably be expected to have a Material Adverse Effect.

4.8

Authorization of Stock Purchase Contracts and Common Stock. As of the Closing Date, the Stock Purchase Contracts will be duly authorized by all necessary corporate action on the part of the Company and will be valid and binding obligations of the Company enforceable against the Company in accordance with their respective terms, except as the same may be limited by applicable bankruptcy, insolvency, reorganization, moratorium or similar laws affecting the enforcement of creditors’ rights generally and

A-6

general equitable principles, regardless of whether such enforceability is considered in a proceeding at law or in equity (“Bankruptcy Exceptions”).

The issuance of the shares of the Common Stock underlying the Stock Purchase Contracts has been duly authorized by all necessary corporate action on the part of the Company and upon the issuance of the Common Stock underlying the Stock Purchase Contracts, such shares of Common Stock will (A) be duly authorized by all necessary corporate action on the part of the Company, (B) be validly issued, fully paid and nonassessable, (C) not have been issued in violation of any preemptive or other similar right, and (D) if such shares are treasury shares, be free of any adverse claim.

4.9

Authorization of the Securities. As of the Closing Date, the Securities will be duly authorized by all necessary corporate action on the part of the issuing parties; and when executed and delivered by the issuing parties, will constitute the valid and binding obligations of the issuing parties, enforceable against each of the issuing parties in accordance with their terms, except as the enforcement thereof may be limited by the Bankruptcy Exceptions.

4.10

The Trusts. As of the Closing Date:

(1) Each of the Trusts will be duly created as a statutory trust and will be validly existing in good standing under the laws of the State of Delaware; each Trust will be classified as a grantor trust and will not be classified as an association taxable as a corporation for United States federal income tax purposes; each Trust will have the power and authority necessary to own or hold its properties and to conduct the businesses in which such Trust is engaged.

(2) The trust agreement for each Trust will have been duly authorized by the Company and will have been duly executed and delivered by the Company, as sponsor and depositor, and, assuming due authorization, execution and delivery of each trust agreement by the applicable trustees, each trust agreement will be a valid and binding obligation of the Company, enforceable against the Company in accordance with its terms, except to the extent that enforcement thereof may be limited by Bankruptcy Exceptions.

(3) The trust preferred securities of each Trust will have been duly authorized by such Trust and, when issued and delivered against payment of the consideration described in this Agreement, will be validly issued and fully paid and non-assessable undivided beneficial interests in the assets of such Trust, will be entitled to the benefits of each applicable trust agreement and will conform in all material respects to the descriptions thereof contained in the Offering Memorandum; the issuance of the trust preferred securities of each Trust will not be subject to preemptive or other similar rights; and the Investor will be entitled to the same limitation of personal liability under Delaware law as extended to stockholders of private corporations for profit.

(4) The common securities issuable by each Trust to the

A-7

Company will have been duly authorized by the Trust and, when issued and delivered by each Trust to the Company will be validly issued and (subject to the terms of the relevant trust agreement) fully paid undivided beneficial interests in the assets of each Trust; the issuance by each Trust of common securities is not subject to preemptive or other similar rights; and upon consummation of the Closing all of the issued and outstanding common securities of each Trust will be directly or indirectly owned by the Company free and clear of any security interest, mortgage, pledge, lien, encumbrance, claim or equity.

4.11

Authorization of the Junior Subordinated Indentures. As of the Closing Date, each junior subordinated indenture of the Company, and each supplement thereto under which a junior subordinated debt security is delivered to a Trust, will have been duly authorized, executed and delivered by the Company and will constitute a valid and legally binding obligation of the Company, enforceable against the Company in accordance with its terms, except to the extent that enforcement thereof may be limited by the Bankruptcy Exceptions.

4.12

Authorization of Junior Subordinated Debt Securities. As of the Closing Date, each junior subordinated debt security delivered to a Trust will have been duly authorized by the Company and duly executed and delivered by the Company to a Trust, and when authenticated, issued and delivered in the manner provided for in each applicable junior subordinated indenture or supplement thereto, will constitute a valid and legally binding obligation of the Company, enforceable against the Company in accordance with its terms, except to the extent that the enforcement thereof may be limited by the Bankruptcy Exceptions, and will be in the form contemplated by, and entitled to the benefits of, the applicable indenture or supplement thereto.

4.13

Authorization of Guarantee Agreements. As of the Closing Date, each guarantee agreement of the Company with respect to trust preferred securities of a Trust will have been duly authorized by the Company, and will have been duly executed and delivered by the Company and, assuming due authorization, execution and delivery by the applicable guarantee trustee, will constitute a valid and legally binding obligation of the Company, enforceable against the Company in accordance with its terms, except to the extent that enforcement thereof may be limited by the Bankruptcy Exceptions.

4.14

Authorization of the Purchase Contract and Pledge Agreements. As of the Closing Date, each purchase contract and pledge agreement entered into by the Company with respect to the Stock Purchase Contracts will have been duly authorized by the Company, will be validly executed and delivered by the Company and assuming due authorization, execution and delivery of such purchase contract and pledge agreement by the other parties thereto, will constitute a valid and binding obligation of the Company, enforceable against the Company in accordance with its terms, except to the extent that the enforcement thereof may be limited by the Bankruptcy Exceptions.

4.15

Authorization of the Registration Rights Agreement. As of the Closing Date, the Registration Rights Agreement will have been duly authorized by the Company, and will be validly executed and delivered by the Company and assuming due authorization, execution and delivery of such agreement by the other party thereto, will constitute a

A-8

valid and binding obligation of the Company, enforceable against the Company in accordance with its terms, except to the extent that the enforcement thereof may be limited by the Bankruptcy Exceptions and except as rights to indemnification and contribution under the Registration Rights Agreement may be limited under applicable law.

4.16

Authorization of this Agreement. This Agreement has been duly authorized, validly executed and delivered by the Company, and assuming due authorization, execution and delivery of this Agreement by the Investor, constitutes a valid and binding obligation of the Company, enforceable against the Company in accordance with its terms, except to the extent that the enforcement thereof may be limited by the Bankruptcy Exceptions.

4.17

Reports. Since November 30, 2005, the Company has timely filed all documents required to be filed with the Commission pursuant to Sections 13(a), 14(a)or 15(d) of the Exchange Act, except where the failure to so file could not reasonably be expected to have a Material Adverse Effect.

The SEC Reports, when they became effective or were filed with the Commission, as the case may be, conformed in all material respects to the requirements of the Securities Act or the Exchange Act, as applicable, and the rules and regulations of the Commission thereunder, and none of such documents contained an untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary to make such statements, in the light of the circumstances in which they were made, not misleading.

Since November 30, 2005, the Company and each subsidiary have filed all material reports, registrations and statements, together with any required amendments thereto, that it was required to file with any applicable federal or state securities or banking authorities, except where the failure to file any such report, registration or statement, individually or in the aggregate, could not reasonably be expected to have a Material Adverse Effect. As of their respective dates, each of the foregoing reports complied with all applicable rules and regulations promulgated by applicable foreign, federal or state securities or banking authorities, as the case may be, except for any failure that, individually or in the aggregate, could not reasonably be expected to have a Material Adverse Effect.

The records, systems, controls, data and information of the Company and the subsidiaries are recorded, stored, maintained and operated under means (including any electronic, mechanical or photographic process, whether computerized or not) that are under the exclusive ownership and direct control of the Company or the subsidiaries or their accountants (including all means of access thereto and therefrom). The Company (i) has implemented and maintains disclosure controls and procedures (as defined in Rule 13a-15(e) under the Exchange Act) to ensure that material information relating to the Company, including its subsidiaries, is made known to the chief executive officer and the chief financial officer of the Company by others within those entities, and (ii) has disclosed, based on its most recent evaluation prior to the date hereof, to the Company’s outside auditors and the audit committee of the Company’s board of directors (A) any significant deficiencies and material weaknesses in the design or

A-9

operation of internal controls over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act) that, individually or in the aggregate, could reasonably be expected to adversely affect the Company’s ability to record, process, summarize and report financial information and (B) any fraud, whether or not material, that involves management or other employees who have a significant role in the Company’s internal controls over financial reporting. As of the date hereof, to the knowledge of the Company, there is no reason that its outside auditors and its chief executive officer and chief financial officer will not be able to give the certifications and attestations required pursuant to the rules and regulations adopted pursuant to Section 404 of the Sarbanes-Oxley Act of 2002, without qualification, when next due.

4.18

Subprime Exposure. After giving effect to the write downs described in the press release and related financial supplement referred to in Section 17 below, as of November 30, 2007, the aggregate remaining total U.S. ABS CDO/Subprime Net Exposure of the Company and its subsidiaries was $1.8 billion. As used in this paragraph, “Net Exposure” means the potential loss to the Company in the event of a 100% default, assuming zero recovery, over a period of time.

As used in this Article IV, “Material Adverse Effect” means any fact, circumstance, event, change, effect or occurrence that, individually or in the aggregate with all other facts, circumstances, events, changes, effects, or occurrences, has a material adverse effect on (i) the business, assets, liabilities, results of operation or financial condition of the Company and its subsidiaries taken as a whole or (ii) the ability of the Company to consummate the transactions contemplated by this Agreement, other than, in each case, any adverse effect resulting from the announcement of the transactions contemplated by this Agreement.

5. Representations, Warranties and Covenants of the Investor.

The Investor and the Guarantor each hereby represents and warrants to, and covenants with, the Company that:

5.1.

(1) It is (a) a QIB and is an “accredited investor” within the meaning of Rule 501 of Regulation D promulgated under the Securities Act, (b) aware that the sale to it is being made in reliance on a private placement exemption from registration under the Securities Act and (c) acquiring the Securities for its own account or for the account of a QIB.

(2) It understands and agrees on behalf of itself and on behalf of any investor account for which it is purchasing Securities, and each subsequent holder of a Security or shares of Common Stock issued upon settlement of the Stock Purchase Contracts by its acceptance thereof will be deemed to agree, that the Securities and Common Stock issuable upon settlement of the Stock Purchase Contracts are being offered in a transaction not involving any public offering within the meaning of the Securities Act, that the Securities and Common Stock issuable upon settlement of the Stock Purchase Contracts have not been and, except as described in the Offering Memorandum or contemplated by the Registration Rights Agreement, will not be registered under the Securities Act and that, unless the Securities are sold in a registered offering under the Securities Act, (a) it may offer, sell, pledge or otherwise transfer any of the Securities only to a person whom the

A-10

seller reasonably believes is a QIB in a transaction not involving a public offering and (b) if prior to the expiration of the applicable holding period specified in Rule 144(k) of the Securities Act (or any successor provision) it decides to offer, resell, pledge or otherwise transfer any of the Common Stock issued upon settlement of the Securities, such Common Stock may be offered, resold, pledged or otherwise transferred only (i) to a person whom the seller reasonably believes is a QIB in a transaction not involving a public offering, (ii) pursuant to an exemption from registration under the Securities Act provided by Rule 144 thereunder (if available), (iii) pursuant to an effective registration statement under the Securities Act, or (iv) to the Company or one of its subsidiaries, in each of cases (i) through (iv) in accordance with any applicable securities laws of any State of the United States, and that (c) it will, and each subsequent holder is required to, notify any subsequent purchaser of the Securities or Common Stock from it of the resale restrictions referred to in (a) and (b) above, as applicable, and will provide the Company and the transfer agent such certificates and other information as they may reasonably require to confirm that the transfer by it complies with the foregoing restrictions, if applicable.

(3) It understands that, unless the Securities are registered under the Securities Act, (a) the Securities and (b) until the expiration of the applicable holding period set forth in Rule 144(k) of the Securities Act (or any successor provision), unless sold pursuant to a registration statement that has been declared effective under the Securities Act or in compliance with Rule 144, the Common Stock issued upon settlement of the Securities will bear a legend substantially to the following effect:

THIS SECURITY (OR ITS PREDECESSOR) WAS ORIGINALLY ISSUED IN A TRANSACTION EXEMPT FROM REGISTRATION UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED, (THE “SECURITIES ACT”), AND THIS SECURITY MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED IN THE ABSENCE OF SUCH REGISTRATION OR AN APPLICABLE EXEMPTION THEREFROM.

THE HOLDER OF THIS SECURITY AGREES FOR THE BENEFIT OF THE COMPANY THAT (A) THIS SECURITY MAY BE OFFERED, RESOLD, PLEDGED OR OTHERWISE TRANSFERRED, ONLY (I) TO A PERSON WHOM THE SELLER REASONABLY BELIEVES IS A QUALIFIED INSTITUTIONAL BUYER (AS DEFINED IN RULE 144A UNDER THE SECURITIES ACT) IN A TRANSACTION NOT INVOLVING A PUBLIC OFFERING, (II) PURSUANT TO ANY OTHER EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT, INCLUDING RULE 144 UNDER THE SECURITIES ACT (IF AVAILABLE) SUBJECT TO THE ISSUER’S RIGHT PRIOR TO ANY SUCH OFFER, SALE OR TRANSFER PURSUANT TO CLAUSE (II) TO REQUIRE THE DELIVERY OF AN OPINION OF COUNSEL, CERTIFICATION AND/OR OTHER INFORMATION SATISFACTORY TO IT, (III) PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR (IV) TO THE COMPANY OR ANY OF ITS SUBSIDIARIES, IN EACH OF CASES (I) THROUGH (IV) IN ACCORDANCE WITH ANY APPLICABLE SECURITIES LAWS OF ANY STATE OF THE UNITED STATES, AND (B) THE HOLDER WILL, AND EACH SUBSEQUENT HOLDER IS REQUIRED TO, NOTIFY ANY SUBSEQUENT

A-11

PURCHASER OF THIS SECURITY FROM IT OF THE RESALE RESTRICTIONS REFERRED TO IN (A) ABOVE.

(4) It:

(a) is able to fend for itself in the transactions contemplated by the offering memorandum referred to below;

(b) has such knowledge and experience in financial and business matters as to be capable of evaluating the merits and risks of its prospective investment in the Securities; and

(c) has the ability to bear the economic risks of its prospective investment and can afford the complete loss of such investment.

(5) It has received a copy of the Offering Memorandum and acknowledges that (a) it has conducted its own investigation of the Company and the terms of the Securities, (b) it has had access to the Company’s public filings with the Securities and Exchange Commission and to such financial and other information as it deems necessary to make its decision to purchase the Securities, and (c) has been offered the opportunity to ask questions of the Company and received answers thereto, as it deemed necessary in connection with the decision to purchase the Securities.

(6) It understands that the Company will rely upon the truth and accuracy of the foregoing representations, acknowledgements and agreements and agrees that if any of the representations and acknowledgements deemed to have been made by it by its purchase of the Securities is no longer accurate, it shall promptly notify the Company. If it is acquiring Securities as a fiduciary or agent for one or more investor accounts, it represents that is has sole investment discretion with respect to each such account and it has full power to make the foregoing representations, acknowledgements and agreements on behalf of such account.

5.2.

Each of the Investor and the Guarantor acknowledges that the Common Stock is listed on the New York Stock Exchange and the Company is required to file reports containing certain business and financial information with the Securities and Exchange Commission pursuant to the reporting requirements of the Securities Exchange Act of 1934, as amended, and that it is able to obtain copies of such reports.

5.3.

Each of the Investor and the Guarantor acknowledges that no action has been or will be taken in any jurisdiction outside the United States by the Company that would permit an offering of the Securities, or possession or distribution of offering materials in connection with the issue of the Securities, in any jurisdiction outside the United States where action for that purpose is required. Each such person outside the United States will comply with all applicable laws and regulations in each foreign jurisdiction in which it purchases, offers, sells or delivers Securities or has in its possession or distributes any offering material, in all cases at its own expense.

5.4.

Each of the Investor and the Guarantor has full right, power, authority and capacity to enter into this Agreement and to consummate the transactions contemplated hereby and

A-12

has taken all necessary action to authorize the execution, delivery and performance of this Agreement.

5.5.

Each of the Investor and the Guarantor understands that nothing in the Offering Memorandum, this Agreement, the Company’s public filings with the Securities and Exchange Commission or any other materials presented to the Investor in connection with the purchase and sale of the Securities constitutes legal, tax or investment advise. Each of the Investor and the Guarantor has consulted such legal, tax and investment advisors as it, in its sole discretion, has deemed necessary or appropriate in connection with its purchase of the Securities and has made its own assessment and has satisfied itself concerning the relevant tax and other economic considerations relevant to its investment in the Securities.

5.6

To the best of each of its knowledge, after reasonable inquiry, as of the date hereof, neither the Investor nor the Guarantor, nor any of their respective Controlled Affiliates, directly or indirectly owns, controls or has the power to vote any voting securities of the Company or any securities convertible into or exercisable or exchangeable for voting securities of the Company. As of the additional Closing Date, if any, pursuant to Section 2.1, neither the Investor nor the Guarantor, nor any of their respective Controlled Affiliates, will directly or indirectly own, control or have the power to vote any voting securities of the Company or any securities convertible into or exercisable or exchangeable for voting securities of the Company in excess of 0.15% of the total shares outstanding of the Company’s Common Stock on November 30, 2007 or such later date as relevant under Section 2.1, excluding for purposes of this calculation the Securities purchased pursuant to this Agreement. The term “Controlled Affiliate” means, when used with reference to a specified Person, any Person directly or indirectly controlling or controlled by or under direct or indirect common control with the Person specified or with the power, directly or indirectly, to direct the management or policies of such Person or to vote 25 percent or more of any class of voting securities of such Person, as interpreted by the Federal Deposit Insurance Corporation for purposes of the Change in Bank Control Act, 12 U.S.C. �1817(j), or 12 C.F.R. Part 303, Subpart E.

5.7

In addition to the transfer restrictions set forth in Section 5.1, (a) the Investor shall not offer, sell, pledge or otherwise transfer any of the Securities or the Common Stock issued upon settlement of the Securities or Hedge its exposure to the Common Stock prior to the first anniversary of the Closing Date and (b) on or after the first anniversary of the Closing Date until the first anniversary of the last date on which the Investor receives Common Stock in settlement of its Securities, the Investor shall not, within any period of three months, offer, sell, pledge or otherwise transfer Securities or Common Stock issued upon settlement of the Securities or Hedge its exposure to Common Stock, in one transaction or a series of transactions involving the Securities or the Common Stock, having an aggregate value exceeding $2.5 billion, in each case, other than (i) to Affiliates controlled by the Investor or the Guarantor that agree to be bound by the provisions of this Agreement or (ii) as may be required by order or decree of any Governmental Entity having jurisdiction over the Investor or in the reasonable discretion of the Investor to comply with any applicable statute, rule or regulation. The

A-13

Investor shall immediately notify the Company if it engages in any of the transactions referred to in this Section.

“Hedge” means, in respect of the Common Stock, to enter into any swap or any other agreement or any transaction that hedges or transfers, in whole or in part, directly or indirectly, the economic consequence of ownership of such Common Stock, whether any such transaction or swap described is to be settled by delivery of securities, in cash or otherwise.

5.8.

Neither the Investor nor the Guarantor will, and neither will permit any of its Controlled Affiliates to, purchase or otherwise acquire, or agree or offer to purchase or otherwise acquire, ownership, control or the power to vote any voting securities of the Company or any securities convertible into or exercisable or exchangeable for voting securities of the Company, including without limitation Mandatorily Convertible Securities, if, after giving effect thereto, the Investor and the Guarantor, together with their respective Controlled Affiliates, would, directly or indirectly, own, control or have the power to vote more than 9.90% of all voting securities of the Company. For purposes of this paragraph, the number of shares of Common Stock underlying convertible or exchangeable securities on any date will be determined on a fully converted basis and, for purposes of the Securities, deemed to be the number of shares the Investor would receive upon an early settlement at the Settlement Rate of the Securities as a result of a Cash Merger.

5.9

The Investor will remain a Controlled Affiliate of the Guarantor for so long as the Investor owns any Securities.

6. Survival of Representations, Warranties and Agreements. Notwithstanding any investigation made by any party to this Agreement, all covenants, agreements, representations and warranties made by the Company, the Investor and the Guarantor herein shall survive the execution of this Agreement, the delivery to the Investor of the Securities being purchased and the payment therefor.

7. Notices. All notices, requests, consents and other communications hereunder shall be in writing, shall be delivered (A) if within the domestic United States, by first-class registered or certified mail, or nationally recognized overnight express courier, postage prepaid, or by facsimile, or (B) otherwise by International Federal Express or facsimile, and shall be deemed given (i) if delivered by first-class registered or certified mail, three business days after so mailed, (ii) if delivered by a nationally recognized overnight carrier, one business day after so mailed, (iii) if delivered by International Federal Express, two business days after so mailed and (iv) if delivered by facsimile, upon electronic confirmation of receipt and shall be delivered as addressed as follows:

(a)

if to the Company, to:

Morgan Stanley

Attention: Chief Financial Officer

1585 Broadway

New York, NY 10036

A-14

(b)

if to the Investor or the Guarantor, at its address on the signature page hereto, or at such other address or addresses as may have been furnished to the Company in writing.

8. Changes. Except as contemplated herein, this Agreement may not be modified or amended except pursuant to an instrument in writing signed by the Company and the Investor.

9. Headings. The headings of the various sections of this Agreement have been inserted for convenience or reference only and shall not be deemed to be part of this Agreement.

10. Severability. In case any provision contained in this Agreement should be invalid, illegal or unenforceable in any respect, the validity, legality and enforceability of the remaining provisions contained herein shall not in any way be affected or impaired thereby.

11. Integration. This Agreement supersedes all prior agreements and understandings (whether written or oral) between the Company and the Investor and the Guarantor, or either of them, with respect to the subject matter hereof.

11. Applicable Law and Submission to Jurisdiction.

(a)	This Agreement will be governed by and construed in accordance with the laws of the State of New York applicable to contracts made and to be performed within the State of New York.

(b)

Each of the Investor and the Guarantor irrevocably submits to the non-exclusive jurisdiction of any New York State or United States Federal court sitting in The City of New York over any suit, action or proceeding arising out of or relating to this Agreement or the transactions contemplated thereby. Each of The Investor and the Guarantor irrevocably waives, to the fullest extent permitted by law, any objection which it may now or hereafter have to the laying of venue of any such suit, action or proceeding brought in such a court and any claim that any such suit, action or proceeding brought in such a court has been brought in an inconvenient forum. To the extent that the Investor or the Guarantor has or hereafter may acquire any immunity (on the grounds of sovereignty or otherwise) from the jurisdiction of any court or from any legal process with respect to itself or its property, it irrevocably waives, to the fullest extent permitted by law, such immunity in respect of any such suit, action or proceeding.

12. Counterparts. This Agreement may be signed in one or more counterparts, each of which shall constitute an original and all of which together shall constitute one and the same agreement.

13. Preemptive Rights.

(a) Company Sale of Covered Securities.

If the Company offers to sell Covered Securities in a Qualified Offering, the Investor shall be afforded the opportunity to acquire from the Company, for the same price and on the same terms as such Covered Securities are offered, in the aggregate up to the amount of Covered Securities required to enable it to maintain its then-current Investor Percentage Interest; provided, however, that this Section 13 shall not apply to any Qualified Offering the gross proceeds of which, together with the aggregate gross

A-15

proceeds of any other Qualified Offering of Covered Securities after the date hereof, do not exceed $500,000,000.

(b) Notice.

(1) In the event the Company intends to make a Qualified Offering of Covered Securities that is an underwritten public offering or a private offering made to Qualified Institutional Buyers (as such term is defined in Rule 144A under the Securities Act) for resale pursuant to Rule 144A under the Securities Act, the Company shall give the Investor written notice of its intention (including, in the case of a registered public offering and to the extent possible, a copy of the prospectus included in the registration statement filed in respect of such offering), describing, to the extent then known, the anticipated amount of securities, price and other material terms upon which the Company proposes to offer the same. The Investor shall have one Business Day from the date of receipt of any such notice to notify the Company in writing that it intends to exercise such preemptive purchase rights and as to the amount of Covered Securities the Investor desires to purchase, up to the maximum amount calculated pursuant to Section 13(a) (the “Designated Securities”). Such notice shall constitute a non-binding indication of interest of Investor to purchase the Designated Securities so specified at the range of prices and other terms set forth in the Company’s notice to it. The failure to respond during such one Business Day period shall constitute a waiver of preemptive rights in respect of such offering. To the extent the Company shall give the Investor notice of any such offer prior to the public announcement thereof, the Investor shall agree to confidentiality and restriction on trading terms reasonably acceptable to the Company. The failure of the Investor to agree to such terms within one Business Day after the date of receipt of the Company’s notice as described in this clause shall constitute a waiver of the Investor’s preemptive rights in respect of such offering.

(2) If the Company proposes to make a Qualified Offering of Covered Securities that is not an underwritten public offering or Rule 144A offering (a “Private Placement”), the Company shall give the Investor written notice of its intention, describing, to the extent then known, the anticipated amount of securities, price and other material terms upon which the Company proposes to offer the same. The Investor shall have one Business Day from the date of receipt of the notice required by the immediately preceding sentence to notify the Company in writing that it intends to exercise such preemptive purchase rights and as to the amount of Designated Securities the Investor desires to purchase, up to the maximum amount calculated pursuant to Section 13(a). Such notice shall constitute a non-binding indication of interest of Investor to purchase the amount of Designated Securities so specified (or a proportionately lesser amount if the amount of Covered Securities to be offered in such Private Placement is subsequently reduced) upon the price and other terms set forth in the Company’s notice to it. The failure of the Investor to respond during the one Business Day period referred to in the second preceding sentence shall constitute a waiver of the preemptive rights in respect of such offering. To the extent the Company shall give the Investor notice of any such offer prior to the public announcement thereof, the Investor shall agree to confidentiality and restriction on trading terms reasonably acceptable to the Company. The failure of the Investor to agree to such terms within one Business Day after the date of receipt of the Company’s notice as described in this clause shall constitute a waiver of the Investor’s preemptive rights in respect of such offering.

A-16

(1) If the Investor exercises its preemptive purchase rights provided in Section 13(b)(1), the Company shall offer the Investor, if such underwritten public offering or Rule 144A offering is consummated, the Designated Securities (as adjusted to reflect the actual size of such offering when priced) at the same price as the Covered Securities are offered to the investors in such offering and shall provide written notice of such price to the Investor as soon as practicable prior to such consummation. Contemporaneously with the execution of any underwriting agreement or purchase agreement entered into between the Company and the underwriters or initial purchasers of such underwritten public offering or Rule 144A offering, the Investor shall, if it continues to wish to exercise its preemptive rights with respect to such offering, enter into an instrument in form and substance reasonably satisfactory to the Company acknowledging the Investor’s binding obligation to purchase the Designated Securities to be acquired by it and containing representations, warranties and agreements of the Investor that are customary in private placement transactions and, in any event, no less favorable to the Investor than any underwriting or purchase agreement entered into by the Company in connection with such offering, and the failure to enter into such an instrument at or prior to such time shall constitute a waiver of preemptive rights in respect of such offering. Any offers and sales pursuant to this Section 13 in the context of a registered public offering shall be also conditioned on reasonably acceptable representations and warranties of the Investor regarding its status as the type of offeree to whom a private sale can be made concurrently with a registered offering in compliance with applicable securities laws.

(2) If the Investor exercises its preemptive rights provided in Section 13(b)(2), the closing of the purchase of the Covered Securities with respect to which such right has been exercised shall be conditioned on the consummation of the Private Placement giving rise to such preemptive purchase rights and shall take place simultaneously with the closing of the Private Placement or on such other date as the Company and the Investor shall agree in writing; provided that the actual amount of Covered Securities to be sold to the Investor pursuant to its exercise of preemptive rights hereunder shall be reduced if the aggregate amount of Covered Securities sold in the Private Placement is reduced and, at the option of the Investor (to be exercised by delivery of written notice to the Company within five business days of receipt of notice of such increase), shall be increased if such aggregate amount of Covered Securities sold in the Private Placement is increased. In connection with its purchase of Designated Securities, Investor shall, if it continues to wish to exercise its preemptive rights with respect to such offering, execute an agreement containing representations, warranties and agreements of Investor that are substantially similar in all material respects to the agreements executed by other purchasers in such Private Placement.

(d) Cooperation. The Company and the Investor shall cooperate in good faith to facilitate the exercise of the Investor’s preemptive rights hereunder, including securing any required approvals or consents, in a manner that does not jeopardize the timing, marketing, pricing or execution of any offering of the Company’s securities.

(e) Limitation of Rights. Notwithstanding the above, nothing set forth in this Section 13 shall confer upon the Investor the right to purchase any securities of the Company other than Designated Securities.

A-17

(f) Termination of Preemptive Rights. Anything to the contrary in this Section 13 notwithstanding, the preemptive right to purchase Covered Securities granted by this Section 13 shall not be available for any offering that commences at any time after the earlier of (i) the Stock Purchase Date or (ii) the date on which the Investor offers, sells, pledges or otherwise transfers any of the Securities that it acquired on the Closing Date or the Common Stock issued upon settlement of the Securities, or Hedges its exposure to the Common Stock, except as contemplated by Section 5.7(b)(i) or (ii). The Investor shall immediately notify the Company if it engages in any of the transactions referred to in this Section.

(g) For purposes of this Section 13:

(1) “Business Day” means any day other than a Saturday or Sunday, or a day on which banking institutions in The City of New York or Beijing, China are authorized or required by law, regulation or executive order to remain closed.

(2) “Covered Securities” means the Common Stock and any securities convertible into or exercisable or exchangeable for Common Stock that are not Excluded Securities.

(3) “Excluded Securities” means any securities that are (A) issued by the Company pursuant to any employment contract, employee or benefit plan, stock purchase plan, stock ownership plan, stock option or equity compensation plan or other similar plan where stock is being issued or offered to a trust, other entity or otherwise, to or for the benefit of any employees, potential employees, officers or directors of the Company, (B) issued by the Company in connection with a business combination or other merger, acquisition or disposition transaction, (C) issued with reference to the Common Stock of a subsidiary (i.e., a carve-out transaction) or (D) issued in connection with a dividend investment or stockholder purchase plan;

(4) “Investor Percentage Interest” means as of any date, the percentage equal to (i) the aggregate number of shares of Common Stock beneficially owned by the Investor (treating the Securities and other convertible securities of the Company that are beneficially owned by the Investor or its Affiliates as fully converted into the underlying Common Stock) divided by (ii) the total number of outstanding shares of Common Stock after giving effect to the issuance to the Investor of all Shares described in clause (i). For purposes of this paragraph, the number of shares of Common Stock into which the Securities are convertible on any date will be deemed to be the number of shares the Investor would receive upon an early settlement at the Settlement Rate of the Securities as a result of a Cash Merger.

(5) “Qualified Offering” means a public or nonpublic offering of Covered Securities (other than Excluded Securities) solely for cash.

14. Threshold Appreciation Price Reset Provisions.

(a) If during the period commencing on the date of this Agreement and ending on the 12 month anniversary of the Closing Date (the “Reset Test Period”) the Company sells any Reset Triggering Securities and the aggregate gross proceeds from all such sales of Reset Triggering Securities during such period exceeds $1 billion (such occurrence a “Reset Event”), then, no later than the Amendment Deadline, the Company shall amend the Stock Purchase Contracts held by the Investor named this in this Agreement (the

A-18

“Affected Stock Purchase Contracts”) as provided in the remainder of this Section 14. To the extent any such amendment shall require the consent of such Investor as holder of the Stock Purchase Contracts pursuant to the terms of the Securities, the Investor hereby agrees to give such consent as necessary to effect such amendment (it being understood, for the avoidance of doubt, that this sentence will not otherwise create or give the Investor any such right to consent).

(b) If a Reset Event occurs and the Reset Triggering Securities include shares of Common Stock, then the Company shall amend each Affected Stock Purchase Contract so that the Threshold Appreciation Price as adjusted equals (x) the Applicable Stock Price multiplied by (y) 1.20.

(c) If a Reset Event occurs and the Reset Triggering Securities include Optionally Convertible Securities or Mandatorily Convertible Securities, then the Company shall amend each Affected Stock Purchase Contract so that the Threshold Appreciation Price as adjusted equals the Applicable Conversion or Threshold Appreciation Price for any of such securities.

(e) If in connection with the occurrence of a Reset Event the Company has issued Reset Triggering Securities triggering adjustments under both of the preceding two paragraphs, then the Company shall, in lieu of the adjustments contemplated in such paragraphs, amend each Stock Purchase Contract so that the Threshold Appreciation Price as adjusted equals the lowest Threshold Appreciation Price calculated pursuant to those paragraphs.

(f) If any provision of this Section 14 would (in the absence of this sentence) result in an adjusted Threshold Appreciation Price that is less than the Reference Price, the adjusted Threshold Appreciation Price shall instead be the Reference Price. No adjustment shall be made to the Threshold Appreciation Price if that would result in an increase in the Threshold Appreciation Price.

(g) It is understood and agreed that if any anti-dilution adjustments are made to the Stock Purchase Contracts pursuant to the terms thereof, appropriate changes will be made to the adjustments and related definitions set forth in this Section 14 to preserve the economic intent of this Section 14 and without any duplication to any such adjustment set forth in the Stock Purchase Contracts.

(h) Anything to the contrary in this Section 14 notwithstanding, the provisions of this Section 14 shall not apply, and no adjustment shall made to the Threshold Appreciation Price or otherwise pursuant to this Agreement, if a Reset Event occurs on or after the date on which the Investor (i) offers, sells, pledges or otherwise transfers any of the Securities that it acquired on the Closing Date or the Common Stock issued upon settlement of the Securities, or Hedges its exposure to the Common Stock, or (ii) settles any of the Stock Purchase Contracts pursuant to the terms of the Securities, in each case except as contemplated by Section 5.7(b)(i) or (ii). The Investor shall immediately notify the Company if it engages in any of the transactions referred to in this Section.

(i) For purposes of this Section 14:

“Adjusted Conversion or Threshold Appreciation Price” means, for any Optionally Convertible Securities or Mandatorily Convertible Securities, the conversion price or threshold appreciation price for such securities; provided, however, if the aggregate

A-19

stated yield for such securities is greater than 9.0%, the Company and the Investor entitled to an adjustment pursuant to this Section will attempt in good faith to mutually agree on a hypothetical conversion price or threshold appreciation price that would preserve the same fair market value for such securities assuming such securities had borne an aggregate stated yield of 9.0%. If the Company and such Investor cannot mutually agree on such hypothetical conversion price or threshold appreciation price, they will appoint an independent investment bank of national standing to do the calculation for them and the cost of that bank will be divided between the parties.

“Amendment Deadline” means the date that is the earliest to occur of (i) the day before the Stock Purchase Date under the Stock Purchase Contracts, (ii) the day before any Early Settlement Date (whether pursuant to a cash merger or otherwise) under any of the Stock Purchase Contracts and (iii) the date of any sale of the Securities by the Investor in accordance with the terms of the Securities and this Agreement (but in the case of this clause (iii), in no event earlier than 5 Business Days following the last day of the Reset Test Period).

“Applicable Conversion or Threshold Appreciation Price” means, with respect to Reset Triggering Securities consisting of Optionally Convertible Securities or Mandatorily Convertible Securities sold during the Reset Test Period, the lower of (i) the weighted average Adjusted Conversion or Threshold Appreciation Price for such securities and (ii) the lowest Adjusted Conversion or Threshold Appreciation Price for any such securities sold in any single offering with gross proceeds of more than $100 million.

“Applicable Stock Price” means, with respect to Reset Triggering Securities consisting of Common Stock sold during the Reset Test Period, the lower of (i) the weighted average price per share at which shares of such Common Stock are sold and (ii) the lowest price per share at which shares of Common Stock are sold in any single offering with gross proceeds of more than $100 million.

“Mandatorily Convertible Securities” means additional PEPS or any other securities (including securities consisting of units that are a combination of securities) that are mandatorily convertible into or exchangeable for common equity of the Company.

“Optionally Convertible Securities” means securities that are convertible into or exchangeable for common equity of the Company at the option of the holder thereof.

“Reference Price” means the reference price referred to in the Offering Memorandum.

“Reset Triggering Securities” means any one or more of the following that are not Excluded Securities (as defined in Section 13):

(1) Common Stock sold at a price per share less than the Reference Price and

(2) Optionally Convertible Securities or Mandatorily Convertible Securities having an Adjusted Conversion or Threshold Appreciation Price that is less than the Threshold Appreciation Price;

provided, however, any Security issued upon exercise of rights issued in a rights offering to shareholders with respect to which an adjustment was effected in the Stock Purchase Contracts shall not constitute a Reset Triggering Security.

A-20

“Threshold Appreciation Price” means the threshold appreciation price referred to in the Offering Memorandum (as it may be adjusted pursuant to this Agreement).

15. Taxes:

(a) Payments to Exempt Holders.

All payments made by the Company and any trust with respect to the Securities, the treasury units, the stock purchase contract, the trust preferred securities, the junior subordinated debentures, the subordinated notes, the qualifying treasury securities and the treasury portfolio and any other payment made on, or with respect to, the Securities (the “Payments”) shall be made free and clear of, and without deduction or withholding for or on account of, any United States federal, state and local withholding taxes, stamp or other taxes, levies, imposts, duties, charges, fees or deductions, hereafter imposed, levied, collected, withheld or assessed by any governmental authority (the “Taxes”), provided that the Company or its paying agent has received in respect of such Payments an unexpired, complete and executed IRS Form W-8EXP (or appropriate substitute form) from the holders of the Securities, treasury units, the trust preferred securities, the subordinated notes, or the junior subordinated debentures, as applicable (an “Exempt Holder”). If as a result of a change in law (or administrative guidance) any Taxes are deducted or withheld (or required to be deducted or withheld) from any Payments to an Exempt Holder, the amounts so payable shall be increased to the extent necessary to yield (after payment of Taxes) Payments at the rates and in the amounts specified in the Offering Memorandum. It being understood that the increased amounts shall also be payable to any holder that would have been entitled to provide the Company or the paying agent with a complete and executed IRS Form W-8EXP but for such change in law (unless a holder is the holder of any Security, stock purchase contract, trust preferred security, subordinated notes or junior subordinated debenture, at least 3 months prior to such change in law and would have been entitled to provide the Company or the paying agent with a complete and executed IRS Form W-8EXP prior to such change in law but did not so provide). Notwithstanding the preceding two sentences, the Company, the trust and their paying agents shall not be required to increase the Payments if the holder purchased the Securities in a registered offering.

(b) Payments to Non-Exempt Holders.

A. Contract Adjustment Payments. Absent a change in law, the Company and the Investor agree to treat contract adjustment payments on the stock purchase contract as a purchase price adjustment to the price of the common stock to be purchased under the stock purchase contract. Notwithstanding the above, the Company intends to withhold federal income tax with respect to all contract adjustment payments on the stock purchase contract that are made to any holder of Securities that is not an Exempt Holder (a “Non-Exempt Holder”).

B. Interest. Except as required by law, the Company and the trust will not withhold any Taxes with respect to payments made on the trust preferred securities, the subordinated notes, the junior subordinated debentures and the qualifying treasury securities and the treasury portfolio that are part of the Securities (the “Debt Instruments”). If as a result of a repeal or amendment of the portfolio interest exemption under the Internal Revenue Code, the Company, the trust or their paying agents withhold (or are required to withhold) any Tax on payment of interest on the Debt Instruments, then the amounts so payable shall be increased to

A-21

the extent necessary to yield (after payment of such Taxes) payments on the Debt Instruments at the rates and in the amounts specified in the Offering Memorandum. Notwithstanding the preceding sentence, the Company, the trust and their paying agents shall not be required to increase the payments on the Debt Instruments if the holder purchased the Debt Instruments in a registered offering.

C. Recharacterization. Notwithstanding subparagraphs A and B above, if the Securities are recharacterized or treated by the Internal Revenue Service, or by any governmental or judicial authority having jurisdiction with respect to Taxes (the “Taxing Authority”), as anything other than an ownership interest in a stock purchase contract and one or more debt instruments that are separable from the stock purchase contract, and the Company or the trust withhold (or are required to withhold) Tax (that is subject to the jurisdiction of such Taxing Authority) on Payments, then the amounts so payable shall be increased to the extent necessary to yield (after payment of such Taxes) Payments at the rates and in the amounts specified in the Offering Memorandum; provided that the Company, the trust or their paying agents shall not be required to increase the Payment in respect of any Tax with respect to (i) Payments under the stock purchase contract, if the Company establishes, based on explicit judicial authority that such Tax would have been imposed as of the date hereof absent the recharacterization described above, and (ii) all other Payments, if the Company establishes, based on explicit statutory or regulatory authority, that such Tax would have been imposed as of the date hereof absent the recharacterization described above. Notwithstanding the preceding sentence, the Company, the trust and their paying agents shall not be required to increase the Payments if the holder purchased the Securities in a registered offering. Any exclusion from the payment of additional amounts in respect of any Taxes (other than U.S. federal income taxes) under (i) and (ii) of this subsection C shall apply only to holders that are not described in section D below, and any exclusion from the payment of additional amounts under (i) and (ii) of this subsection C shall be limited to the amount of Tax that would have been imposed as of the date hereof absent the recharacterization described above.

D. Non-U.S. Federal Income Taxes. If any Taxes, other than U.S. federal income taxes, are deducted or withheld (or required to be deducted or withheld) from any Payments to a holder of any Security, stock purchase contract, trust preferred security, subordinated note, or junior subordinated debenture, and such Taxes are imposed by a Taxing Authority in a jurisdiction with which such holder has no nexus, then the amounts so payable shall be increased to the extent necessary to yield (after payment of such Taxes) Payments at the rates and in the amounts specified in the Offering Memorandum.

(c) This section 15 is expressly intended to be for the benefit of and, enforceable by, the holders of the Securities, treasury units and Debt Instruments from time to time.

16. Information. The Company agrees to cooperate in good faith with any request by the Investor to furnish the Investor with all information concerning itself, its subsidiaries, directors, officers and stockholders and such other matters as may be reasonably necessary in connection with any statement, filing, notice or application made by or on behalf of the Investor or any of its subsidiaries to any Governmental Entity in connection with the Purchase.

A-22

17. Publicity. On the date hereof. the Company shall issue a press release and related financial supplement substantially in the form of Exhibit B hereto. No other written public release or written announcement concerning the transactions contemplated hereby shall be issued by any party without the prior written consent of the other party (which consent shall not be unreasonably withheld), except as such release or announcement may be required by law or the rules or regulations of any securities exchange, in which case the party required to make the release or announcement shall, to the extent reasonably practicable, allow the other party reasonable time to comment on such release or announcement in advance of such issuance. The provisions of this Section shall not restrict the ability of a party to summarize or describe the transactions contemplated by this Agreement in any prospectus or similar offering document so long as the other party is provided a reasonable opportunity to review such disclosure in advance.

18. Termination. This Agreement may be terminated at any time prior to the Closing:

(a)

by either the Investor or the Company if the Closing shall not have occurred by the 60th calendar day following the date of this Agreement; provided, however, that the right to terminate this Agreement under this Section shall not be available to any party whose failure to fulfill any obligation under this Agreement shall have been the cause of, or shall have resulted in, the failure of the Closing to occur on or prior to such date;

(b)

by either the Investor or the Company in the event that any Governmental Entity shall have issued an order, decree or ruling or taken any other action restraining, enjoining or otherwise prohibiting the transactions contemplated by this Agreement and such order, decree, ruling or other action shall have become final and nonappealable; or

(c)	by the mutual written consent of the Investor and the Company.

In the event of termination of this Agreement as provided in this Section, this Agreement shall forthwith become void and there shall be no liability on the part of either party hereto except that nothing herein shall relieve either party from liability for any breach of this Agreement.

A-23

EXHIBIT I TO TERM SHEET

CONFIDENTIAL OFFERING MEMORANDUM

DATED DECEMBER 19, 2007

DESCRIPTION OF THE PREMIUM EQUITY PARTICIPATING SECURITY UNITS—PEPS^SM UNITS

The following is a summary of the terms of the PEPS Units. This summary, together with the summary of some of the provisions of the related documents described below, contains a description of all of the material terms of the PEPS UNITS but is not necessarily complete.

General

We will issue three separate series of PEPS Units in connection with the purchase contract and pledge agreements (the “purchase contract and pledge agreements”) between us and the holders of a series of PEPS Units, acting through the Bank of New York, which we refer to as the “stock purchase contract agent” or the “collateral agent” as applicable. The PEPS Units of each series may be either Corporate Units or Treasury Units. Unless indicated otherwise, “PEPS Units” will include both Corporate Units and Treasury Units. The PEPS Units of each series initially will consist of Corporate Units, each with a stated amount of $1,000.

Corporate Units

Each Corporate Unit will consist of a unit composed of:

(a)

a stock purchase contract under which:

(1)

you will agree to purchase from us, and we will agree to sell to you, on the stock purchase date, for $1,000 in cash, a number of shares of our common stock equal to the settlement rate described under “Description of the Stock Purchase Contracts—Purchase of Common Stock”, “—Early Settlement” or “—Early Settlement Upon Cash Merger”, as the case may be. The stock purchase date is expected to be August 17, 2010 (or, if such day is not a business day, the next business day), but, unless the stock purchase contract terminates prior to such date as described under “Description of the Stock Purchase Contracts—Termination,” could be (i) moved to an earlier date in the circumstance described below under “Description of the Stock Purchase Contracts—Early Settlement” or “—Early Settlement Upon Cash Merger,” or (ii) deferred for quarterly periods until as late as August 17, 2011 (or, if such day is not a business day, the next business day) if the prior remarketing attempts are not successful, as described below under “Description of the Trust Preferred Securities—Remarketing”;

(2)

we will pay to you quarterly contract adjustment payments at an annual rate of 3% of the stated amount of $1,000 per stock purchase contract, subject to our right to defer these payments; and

(b)

a remarketable trust preferred security of Morgan Stanley Capital Trust A, Morgan Stanley Capital Trust B or Morgan Stanley Capital Trust C (each a “Morgan Stanley Trust” and collectively, the “Morgan Stanley Trusts) with an initial liquidation amount of $1,000. Each trust preferred security represents an undivided beneficial ownership interest in the assets of the relevant Morgan Stanley Trust. The property trustee of each of the Morgan Stanley Trusts will hold legal title to the assets. The assets of each of the Morgan Stanley Trusts consist solely of one of three separate series (one series per Morgan Stanley Trust) of our junior subordinated debentures due 2042, which we refer to as the “junior subordinated debentures.” Until the remarketing settlement date with respect to a series of trust preferred securities, unless we otherwise defer such payments, we will make quarterly interest payments on each outstanding series of the junior subordinated debentures that relate to the trust preferred securities for which a remarketing settlement date has not occurred, at the annual rate of 6% per year, and each Morgan Stanley Trust will pass through such interest payments when received as distributions on the trust preferred securities. Upon a successful remarketing, interest on the related series of junior subordinated debentures will be reset and will accrue at a Reset Rate as described below.

Unless otherwise specified, all references in this offering memorandum to a “trust preferred security” or “trust preferred securities” shall be to each of the trust preferred securities issued by the three Morgan Stanley Trusts.

Unless otherwise specified, all references in this offering memorandum to a “junior subordinated debenture” or “junior subordinated debentures” shall be to each series of junior subordinated debentures held by the three Morgan Stanley Trusts.

The purchase price of each Corporate Unit will be allocated between the related stock purchase contract and the related trust preferred securities in proportion to their respective fair market values at the time of issuance. We expect that, at the time of issuance, the fair market value of each trust preferred security will be $1,000 and the fair market value of each stock purchase contract will be $0.

This allocation generally will be binding on each beneficial owner of each PEPS Unit but not on the Internal Revenue Service.

As long as a PEPS Unit is in the form of a Corporate Unit, the related trust preferred securities and their proceeds forming a part of such Corporate Units will be pledged to us through the collateral agent, to secure your obligation to purchase our common stock under the related stock purchase contract.

Creating Treasury Units

Unless the treasury portfolio (as defined under “Description of the Trust Preferred Securities — Redemption”) has replaced the trust preferred securities as a component of Corporate Units and other than during the periods described below, you will have the right to substitute qualifying treasury securities (as defined below) for the related trust preferred securities held by the collateral agent, in each case, having an aggregate principal amount at maturity equal to the liquidation amount of the trust preferred securities for which they are substituted. Upon any such exchange, you will receive $1,000 stated amount of Treasury Units and the related trust preferred securities free of the pledge to secure your obligations under the stock purchase contract, and you will be able to trade them separately.

You will be able to exercise this right (i) on any business day until the second business day before the beginning of the first remarketing period in August, 2010 and (ii) after the first remarketing period, on any business day until the stock purchase date for the related stock purchase contract, other than (1) on a day in November, 2010, February, 2011, May, 2011 or August, 2011 that is on or after the second day of the month through the sixteenth day of the month (or the next business day if the last day is not a business day) or (2) from 3:00 P.M., New York City time, on the second business day before the beginning of any remarketing period and until the business day after the end of that remarketing period. For any Corporate Unit, you will also not be able to exercise this right at any time after a successful remarketing of the trust preferred security that is a component of such Corporate Unit. We refer to periods during which exchanges are permitted as “exchange periods.”

Each “Treasury Unit” will be a unit consisting of:

•	a stock purchase contract; and

•	a qualifying treasury security (as defined below).

A “qualifying treasury security” means (i) for any business day prior to August 17, 2010, a zero-coupon U.S. treasury security with a principal amount at maturity of $1,000 that matures at least one business day prior to August 17, 2010 and (ii) at any time after August 17, 2010, if there has not been an earlier successful remarketing, a treasury security having a principal amount of $1,000 and maturing at least one business day prior to the next succeeding November 17, February 17, May 17 or August 17 (each such date a “quarterly date”).

On each distribution date (or as promptly thereafter as the collateral agent and the paying agent determine to be practicable), each holder of Treasury Units will receive a contract adjustment payment (unless we have chosen to defer such payments).

To create the Treasury Units, you must deposit with the collateral agent $1,000 principal amount of qualifying treasury securities for each $1,000 liquidation amount of Corporate Units to be exchanged, transfer your Corporate Units to the transfer agent and deliver the required notice, as described below under “—Exchange Procedures.”

� Qualifying Treasury Securities After the First Remarketing Period

In the event the first remarketing period results in a failed remarketing (as defined below) with respect to any series of trust preferred securities, in order to determine what U.S. treasury security is the qualifying treasury security during any exchange period after the first remarketing period for such series, the issuer or the collateral agent will, for each quarterly date, commencing on August 17, 2010 and ending on the stock purchase date for the related stock purchase contracts or the earlier termination of such stock purchase contracts, or if any such day is not a business day, the immediately succeeding business day, identify:

•	the 13-week treasury bill that matures at least one but not more than six business days prior to that quarterly date; or

•

if no 13-week treasury bill that matures on at least one but more than six business days prior to that quarterly date is or is scheduled to be outstanding or is available in a sufficient principal amount on the immediately preceding quarterly date, the 26-week treasury bill that matures at least one but not more than six business days prior to that quarterly date; or

•

if neither of such treasury bills is or is scheduled to be outstanding or is available in a sufficient principal amount on the immediately preceding quarterly date, any other treasury security (which may be a zero coupon treasury security) that is outstanding on the immediately preceding quarterly date, is highly liquid and matures at least one business day prior to that quarterly date; provided that any treasury security identified pursuant to this clause shall be selected in a manner intended to minimize the cash value of the security selected.

A “failed remarketing” with respect to any series of trust preferred securities will be deemed to have occurred for each of the first four remarketing periods if the remarketing agent is unable to remarket such trust preferred securities for settlement on or before August 17, 2010, November 17, 2010, February 17, 2011 or May 17, 2011 (or if any such day is not a business day, the next business day), as applicable.

In the event the first remarketing period results in a failed remarketing with respect to any series of trust preferred securities, the issuer or the collateral agent shall use commercially reasonable efforts to identify the security meeting the foregoing criteria for each quarterly date promptly after the Department of the Treasury makes the schedule for upcoming auctions of U.S. treasury securities publicly available and shall, to the extent that a security previously identified with respect to any quarterly date is no longer expected to be outstanding on the immediately preceding quarterly date, identify another security meeting the foregoing criteria for such quarterly date. The security most recently identified by the issuer or the collateral agent with respect to any quarterly date shall be the qualifying treasury security with respect to the period from and including the date it is identified as a qualifying treasury security (or if later, the date of maturity of the qualifying treasury security with respect to the immediately preceding quarterly date) to but excluding its date of maturity, and the issuer’s or the collateral agent's identification of a security as a qualifying treasury security for such period shall be final and binding for all purposes absent manifest error. You will be able to obtain the issue date, the maturity date and, when available, the CUSIP number of the treasury bills or other U.S. treasury securities that are qualifying treasury securities for the current exchange period from the issuer or the collateral agent by calling (212) 762-8131. Since this information is subject to change from time to time, the holders should confirm this information prior to purchasing or delivering U.S. treasury securities in connection with any exchange of Corporate Units for Treasury Units after a failed remarketing.

Each qualifying treasury security delivered to the collateral agent in connection with any exchange of Corporate Units and qualifying treasury securities for Treasury Units and trust preferred securities will be pledged to us through the collateral agent to secure your obligation to purchase shares of our common stock under the corresponding stock purchase contracts. In purchasing qualifying treasury securities after a failed remarketing, the collateral agent will solicit offers from at least three U.S. government securities dealers, one of which may be The Bank of New York or an affiliate of The Bank of New York, which also acts as our collateral agent, and will accept the lowest offer so long as at least two offers are available. The collateral agent shall have no liability to the Morgan Stanley Trusts, any trustee or any holder of the PEPS Units in connection with the purchase of qualifying treasury securities in the absence of gross negligence or willful misconduct.

� Exchange Procedures

To exchange Corporate Units and qualifying treasury securities for Treasury Units and trust preferred securities, for each Corporate Unit you must:

•	deposit with the collateral agent U.S. treasury securities that are qualifying treasury securities on the date of deposit, in a principal amount of $1,000, which you must purchase on the open market at your expense unless you already own them;

•	transfer the Corporate Units to the stock purchase contract agent, accompanied by a notice stating that you are (1) depositing the appropriate qualifying treasury securities with the collateral agent and (2) requesting the delivery to you of Treasury Units and trust preferred securities.

Upon the deposit, and receipt of an instruction from the stock purchase contract agent, the collateral agent will release the trust preferred securities corresponding to the exchanged Corporate Units from the pledge under the purchase contract and pledge agreement, free and clear of our security interest. You will own the related trust preferred securities released to you unencumbered by the security interest created under the purchase contract and pledge agreement and they may be traded separately from the resulting Treasury Units.

Recreating Corporate Units

If you hold Treasury Units you will have the right, at any time during an exchange period, to recreate Corporate Units by substituting for the related qualifying treasury securities held by the collateral agent trust preferred securities having a liquidation amount equal to the aggregate principal amount at stated maturity of the qualifying treasury securities for which substitution is being made.

Each of these substitutions will recreate Corporate Units, and the applicable qualifying treasury securities will be released to the holder unencumbered by the security interest created under the purchase contract and pledge agreement and may be traded separately from the Corporate Units.

To recreate a Corporate Unit, you must:

•	deposit with the collateral agent trust preferred securities with a $1,000 liquidation amount, which you must purchase at your expense unless otherwise owned by you; and

•

transfer Treasury Unit certificates to the stock purchase contract agent; accompanied by a notice stating that you are (1) depositing trust preferred securities with a $1,000 liquidation amount with the collateral agent in substitution for the pledged treasury securities and (2) requesting the release to you of the pledged treasury security relating to the Treasury Units.

Upon the deposit and receipt of an instruction from the stock purchase contract agent, the collateral agent will release the related qualifying treasury securities from the pledge under the purchase contract and pledge agreement, free and clear of our security interest, to the stock purchase contract agent. The stock purchase contract agent will then cancel the Treasury Units, transfer the related treasury security to you, and deliver the recreated Corporate Units to you.

The substituted trust preferred securities and their proceeds will be pledged to us through the collateral agent to secure your obligation to purchase shares of our common stock representing the preferred stock under the related stock purchase contracts.

Current Payments

Subject to the deferral provisions described below, until the stock purchase date for any stock purchase contracts, holders of the related Corporate Units will be entitled to receive quarterly contract adjustment payments payable by us at an annual rate of 3% on the stated amount of $1,000 per Corporate Unit and distributions from the Morgan Stanley Trusts calculated at an annual rate of 6% on the related trust preferred securities.

Subject to the deferral provisions described below, until the stock purchase date for any series of stock purchase contracts, holders of the related series of Treasury Units will be entitled to receive quarterly contract adjustment

payments payable by us at the annual rate of 3% on the stated amount of $1,000 per Treasury Unit. For as long as they hold the separate trust preferred securities, the holders of such series of Treasury Units will continue to receive the scheduled quarterly distribution on the trust preferred securities that were released to them when the Treasury Units were created, subject to our right to defer interest payments on the junior subordinated debentures underlying the trust preferred securities.

Holders of not less than $1,000,000 aggregate stated amount of a series of PEPS Units shall be entitled to receive current payments by wire transfer in immediately available funds on the applicable date of payment.

We may defer the contract adjustment payments until no later than the stock purchase date for any stock purchase contracts as described below under “Description of the Purchase contracts—Option to Defer Contract Adjustment Payments.”

Deferred contract adjustment payments will accrue interest until paid, compounded on each distribution date, at 9% per annum. All accrued and unpaid contract adjustment payments on the stock purchase contracts, including deferred contract adjustment payments and interest thereon, that we do not pay in cash on the stock purchase date (the “unpaid contract adjustment payment amount”), will be paid in the form of additional subordinated notes with a principal amount equal to the unpaid contract adjustment payment amount.

We may also defer cash payments of interest on the junior subordinated debentures that are owned by the Morgan Stanley Trusts, provided that prior to the related stock purchase date, we will not defer the payment of interest with respect to any series of junior subordinated debentures without deferring the payment of interest with respect to all series of junior subordinated debentures, in which case the deferred amounts will accrue additional interest at the applicable rate then borne by the related junior subordinated debentures. As a consequence, the Morgan Stanley Trusts will accumulate corresponding distributions on the related trust preferred securities during the deferral period. Deferred distributions to which you are entitled will accrue interest, compounded quarterly, from the relevant distribution date for distributions during any deferral period, at the rate borne by the junior subordinated debentures at such time, to the extent permitted by applicable law. After we give notice of any deferral of contract adjustment payments or interest on the junior subordinated debentures and during any period that we are deferring contract adjustment payments or interest on the junior subordinated debentures (and, accordingly, the Morgan Stanley Trusts are accumulating distributions on the trust preferred securities) that are otherwise payable in cash, we will be restricted from making certain payments, including declaring or paying any dividends or making any distributions on shares of our capital stock, or redeeming, purchasing, acquiring or making a liquidation payment with respect to, shares of our capital stock, as described under “Description of the Junior Subordinated Debentures—Restrictions on Certain Payments.”

Our obligation to pay contract adjustment payments will be subordinate and junior in right of payment to all our senior debt, to the same extent as our obligations under our junior subordinated debentures, as described under “Description of the Junior Subordinated Debentures.” The ability of the Morgan Stanley Trusts to make the distributions on the trust preferred securities is dependent solely upon the receipt of corresponding payments from us on the related junior subordinated debentures. Our obligations under the junior subordinated debentures are similarly subordinate and junior in right of payment to all our senior debt.

Absence of Rights with Respect to Common Stock

Holders of stock purchase contracts forming part of the Corporate Units or Treasury Units, in their capacities as holders of those securities, will have no voting or other rights (including any rights to receive dividends or other distributions on our common stock for which the record date occurs prior to the stock purchase date) in respect of our common stock until the stock purchase date.

Listing of the Securities

We will not apply to list the PEPS Units on any stock exchange. We will list the shares of common stock that we deliver upon settlement of the stock purchase contacts on the stock exchange or market on which our outstanding shares of common stock are then listed.

Miscellaneous

We or our affiliates may from time to time purchase any PEPS Units that are then outstanding by tender, in the open market or by private agreement.

DESCRIPTION OF THE STOCK PURCHASE CONTRACTS

The following is a summary of some of the terms of the stock purchase contracts and the purchase contract and pledge agreement. This summary, together with the summary of some of the provisions of the related documents described below, contains a description of the material terms of the stock purchase contracts and the purchase contract and pledge agreement but is not necessarily complete.

Purchase of Common Stock

Each stock purchase contract that is a part of a Corporate Unit or a Treasury Unit will obligate its holder to purchase, and us to sell, on the “stock purchase date” for any stock purchase contract, which we expect to be August 17, 2010 but may be an earlier date in the event of an early settlement described under “—Early Settlement” or in the event of a cash merger described under “—Early Settlement Upon Cash Merger,” (unless the stock purchase contract terminates prior to that date), or a date as late as August 17, 2011 due to a deferral for quarterly periods if the prior remarketing attempts are not successful, a number of shares of our common stock equal to the settlement rate, for $1,000 in cash. The number of shares of our common stock issuable upon settlement of each stock purchase contract on the stock purchase date for such stock purchase contract (which we refer to as the “settlement rate”) will be determined as follows, subject to adjustment as described under “—Anti-dilution Adjustments” below:

(1)

If the applicable market value of our common stock is equal to or greater than the “threshold appreciation price” (as defined below), the settlement rate will be the number of shares of our common stock equal to the stated amount divided by the threshold appreciation price (such settlement rate being referred to as the “minimum settlement rate”).

Accordingly, if the market price for the common stock increases between the date of this offering memorandum and the period during which the applicable market value is measured and the applicable market price is greater than the threshold appreciation price, the aggregate market value of the shares of common stock issued upon settlement of each stock purchase contract will be higher than the stated amount, assuming that the market price of the common stock on the stock purchase date is the same as the applicable market value of the common stock. If the applicable market price is the same as the threshold appreciation price, the aggregate market value of the shares issued upon settlement will be equal to the stated amount, assuming that the market price of the common stock on the stock purchase date is the same as the applicable market value of the common stock.

(2)

If the applicable market value of our common stock is less than the threshold appreciation price but greater than the “reference price” (as defined below), the settlement rate will be a number of shares of our common stock equal to $1,000 divided by the applicable market value.

Accordingly, if the market price for the common stock increases between the date of this offering memorandum and the period during which the applicable market value is measured, but the market price does not exceed the threshold appreciation price, the aggregate market value of the shares of common stock issued upon settlement of each stock purchase contract will be equal to the stated amount, assuming that the market price of the common stock on the stock purchase date is the same as the applicable market value of the common stock.

(3)

If the applicable market value of our common stock is less than or equal to the reference price, the settlement rate will be the number of shares of our common stock equal to the stated amount divided by the reference price (such settlement rate being referred to as the “maximum settlement rate”).

Accordingly, if the market price for the common stock decreases between the date of this offering memorandum and period during which the adjusted applicable market value is measured and the market price is less than the reference price, the aggregate market value of the shares of common stock issued upon settlement of each stock purchase contract will be less than the stated amount, assuming that the market price

on the stock purchase date is the same as the applicable market value of the common stock. If the market price of the common stock is the same as the reference price, the aggregate market value of the shares will be equal to the stated amount, assuming that the market price of the common stock on the stock purchase date is the same as the applicable market value of the common stock.

If you elect to settle your stock purchase contract early in the manner described under “—Early Settlement,” the number of shares of our common stock issuable upon settlement of such stock purchase contract will be the minimum settlement rate, subject to adjustment as described under “Anti-dilution Adjustments.” We refer to the minimum settlement rate and the maximum settlement rate collectively as the “fixed settlement rates.”

The “applicable market value” means the arithmetic average of the VWAP for each of the 20 consecutive trading days, subject to adjustment as described below, beginning on and including the twenty-second scheduled trading day immediately preceding August 17, 2010 (we refer to this period as the “observation period”); provided, however, that if we enter into a reorganization event (as defined under “—Anti-dilution Adjustments” below), the applicable market value will mean the value of an exchange property unit (as defined under “—Anti-dilution Adjustments—Reorganization Events” below). Following the occurrence of any such event, references herein to the purchase or issuance of shares of our common stock will be construed to be references to settlement into exchange property units. For purposes of calculating the exchange property unit value, (x) the value of any common stock included in the exchange property unit shall be determined using the arithmetic average of the VWAP for each of the 20 consecutive trading days, subject to adjustment as described below, beginning on and including the twenty-second scheduled trading day immediately preceding August 17, 2010 (or, if the reorganization event shall not have occurred prior to such date, the related stock purchase date for such stock purchase contract) and (y) the value of any other property, including securities other than common stock included in the exchange property unit, shall be the value of such property on the first trading day of the observation period, or if the reorganization event shall not have occurred prior to such date, the twenty-second scheduled trading day prior to the related stock purchase date for such stock purchase contract (as determined in good faith by our board of directors, whose determination shall be conclusive and described in a Board resolution).

The term “reference price” means $48.07.

The term “threshold appreciation price” means 120% of the reference price.

The term “trading day” means a business day on which the relevant exchange or quotation system is scheduled to be open for business on which the shares of our common stock:

�	are not suspended from trading on any national or regional securities exchange or association or over-the-counter market for any period or periods aggregating one half hour or longer; and

�	have traded at least once on the national or regional securities exchange or association or over-the-counter market that is the primary market for the trading of the shares of our common stock.

The term “scheduled trading day” means a day that is scheduled to be a trading day.

The term “VWAP” means, for the relevant measurement day, the per share volume-weighted average price as displayed under the heading Bloomberg VWAP on Bloomberg page MS AQR (or its equivalent successor if such page is not available) in respect of the period from the scheduled open of trading on the relevant trading day until the scheduled close of trading on the relevant trading day (or if such volume-weighted average price is unavailable, the market price of one share of Morgan Stanley common stock on such trading day determined using a volume-weighted average method, by a nationally recognized independent investment banking firm retained by us for this purpose).

If a scheduled trading day during the observation period is not a trading day, we will notify investors of that fact on such scheduled trading day. If 20 trading days for our common stock have not occurred during the observation period prior to the third business day immediately prior to August 17, 2010 or any earlier applicable stock purchase date, as the case may be, all remaining trading days will be deemed to occur on that third business day and the VWAP for each of the remaining trading days will be the VWAP on such third business day or if such day is not a trading day, the VWAP as determined in its reasonable discretion by a nationally recognized independent investment banking firm retained by Morgan Stanley for this purpose.

We will not issue any fractional shares of our common stock upon settlement of a stock purchase contract. Instead of a fractional share, the holder will receive an amount of cash equal to such fraction multiplied by the applicable market value. If, however, a holder surrenders for settlement at one time more than one stock purchase contract, then the number of shares of our common stock issuable pursuant to such stock purchase contracts will be computed based upon the aggregate number of stock purchase contracts surrendered.

Unless:

�	a holder has settled early the related stock purchase contracts by delivery of cash to the stock purchase contract agent in the manner described under “—Early Settlement” or “—Early Settlement Upon Cash Merger;”

�	a holder of Corporate Units has settled the related stock purchase contracts with separate cash in the manner described under “—Notice to Settle with Cash;” or

�	an event described under “—Termination” has occurred,

then, on the stock purchase date for a stock purchase contract,

�

in the case of Corporate Units where there has been a successful remarketing, $1,000 per Corporate Unit of the proceeds from such remarketing will automatically be applied to satisfy in full the holder’s obligations to purchase our common stock under the related stock purchase contracts and any excess proceeds will be delivered to the stock purchase contract agent for the benefit of the holders of Corporate Units;

�

in the case of Corporate Units where there has not been a successful remarketing in the final remarketing period, unless holders of Corporate Units elect not to exercise their put right described under “Description of the Trust Preferred Securities—Remarketing” by delivering cash to settle their stock purchase contracts, such holders will be deemed to have elected to apply the put price to satisfy in full their obligations to purchase our common stock under the related stock purchase contracts and we will deliver to such holders our common stock pursuant to the related stock purchase contracts. We will issue additional subordinated notes in the amount of any accrued and unpaid interest on the junior subordinated debentures (including deferred interest) as of the stock purchase date for such stock purchase contracts to the Morgan Stanley Trusts, which will in turn distribute such notes to the holders of Corporate Units and any separate trust preferred securities and we will pay the unpaid contract adjustment payment amount in additional subordinated notes that will be delivered to the holders of PEPS Units;

�

in the case of Corporate Units where the treasury portfolio has replaced the trust preferred securities as a component of the Corporate Units, proceeds of the appropriate applicable ownership interests in the treasury portfolio when paid at maturity equal to the stated amount of $1,000 per Corporate Unit will automatically be applied to satisfy in full the holder’s obligation to purchase common stock under the related stock purchase contracts and any

excess proceeds will be delivered to the stock purchase contract agent for the benefit of the holders of Corporate Units; and

�

in the case of Treasury Units, the net cash proceeds, when paid at maturity, of the qualifying treasury securities forming part of the Treasury Units or their proceeds automatically will be applied to satisfy in full the holder’s obligation to purchase our common stock under the related stock purchase contracts.

In any event, the common stock will then be issued and delivered to you or your designee, upon presentation and surrender of the certificate evidencing the Corporate Units or Treasury Units, and payment by you of any transfer or similar taxes payable in connection with the issuance of the common stock to any person other than you.

Prior to the settlement of a stock purchase contract, the shares of our common stock underlying each stock purchase contract will not be outstanding, and the holder of the stock purchase contract will not have any voting rights, rights to dividends or other distributions or other rights of a holder of our common stock by virtue of holding such stock purchase contract.

By purchasing a Corporate Unit or a Treasury Unit, a holder will be deemed to have, among other things:

�	irrevocably appointed the stock purchase contract agent as its attorney-in-fact to enter into and perform the stock purchase contract and the related purchase contract and pledge agreement in the name of and on behalf of such holder; and

�	agreed to be bound by the terms and provisions of the Corporate Units and Treasury Units and perform its obligations under the purchase contract and pledge agreement.

In addition, each beneficial owner of a PEPS Unit, by acceptance of the beneficial interest therein, will be deemed to have agreed (i) to treat the acquisition of a PEPS Unit as an acquisition of the related trust preferred security and the related stock purchase contract constituting such PEPS Unit, (ii) to allocate 100% of the purchase price of a PEPS Unit to the related trust preferred security, (iii) to treat for U.S. federal income tax purposes itself as the owner of the related junior subordinated debenture, applicable ownership interests in the treasury portfolio or the qualifying treasury securities, as the case may be, and (iv) to treat the junior subordinated debentures as our indebtedness for all U.S. federal income tax purposes which is not subject to the contingent payment debt regulations.

Early Settlement

Subject to the conditions described below, a holder of Corporate Units or Treasury Units may settle the related stock purchase contracts at any time prior to 5:00 p.m., New York City time, on the second business day immediately preceding the first day of the first remarketing period, in the case of Corporate Units, or the second business day immediately preceding the scheduled stock purchase date for the first remarketing period, in the case of Treasury Units. If the treasury portfolio has replaced the trust preferred securities as a component of the Corporate Units, holders of Corporate Units may settle early only in integral multiples of 200 Corporate Units at any time prior to 5:00 p.m., New York City time, on the second business day immediately preceding the scheduled stock purchase date for the first remarketing period. We refer to this right as the “early settlement right.” In order to settle stock purchase contracts early, a holder of PEPS Units must deliver to the stock purchase contract agent (1) a completed “Election to Settle Early” form, along with the Corporate Unit or Treasury Unit certificate, if they are in certificated form, and (2) a cash payment in immediately available funds in an amount equal to (i) $1,000 times the number of stock purchase contracts being settled plus (ii) if the delivery is made with respect to stock purchase contracts during the period from the close of business on any record date next preceding any distribution date to the opening of business on such distribution date, an

amount equal to the contract adjustment payments payable on the distribution date with respect to the stock purchase contracts.

So long as you hold PEPS Units as a beneficial interest in a global security deposited with the depositary, procedures for early settlement will also be governed by standing arrangements between the depositary and the stock purchase contract agent.

In order to exercise your early settlement right, you must give us written notice of your intention to exercise this right at least 61 days prior to the date of exercise.

Upon early settlement, (1) the holder will receive a number of shares of our common stock per PEPS Unit equal to the minimum settlement rate, subject to adjustment under the circumstances described under “—Anti-dilution Adjustments” below, (2) the related trust preferred securities, junior subordinated debentures, applicable interests in the treasury portfolio or qualifying treasury securities, as the case may be, underlying the PEPS Units and securing such stock purchase contracts will be released from the pledge under the purchase contract and pledge agreement, and delivered within three business days following the early settlement date, in each case to the stock purchase contract agent for delivery to the holder, (3) the holder’s right to receive future contract adjustment payments and any accrued and unpaid contract adjustment payments for the period since the most recent quarterly payment will terminate, except that the holder will receive any accrued and unpaid contract adjustment payments if the early settlement date falls after a record date next preceding any distribution date and prior to opening of business on such distribution date and (4) no adjustment will be made to or for the holder on account of any accrued and unpaid contract adjustment payments referred to in (3) above.

If the stock purchase contract agent receives a completed “Election to Settle Early” form, along with the Corporate Unit or Treasury Unit certificate, if they are in certificated form, and payment of $1,000 for each stock purchase contract being settled prior to 5:00 p.m., New York City time, on any business day and all conditions to early settlement have been satisfied, then that day will be considered the early settlement date with respect to such stock purchase contracts. If the stock purchase contract agent receives the foregoing on or after 5:00 p.m., New York City time, on any business day or at any time on a day that is not a business day, then the next business day will be considered the early settlement date with respect to such stock purchase contracts.

Early Settlement Upon Cash Merger

Prior to the first scheduled remarketing date, if we are involved in a consolidation, acquisition or merger, or a sale of all or substantially all of our assets that is scheduled to close not later than eight business days prior to such remarketing settlement date, in each case in which at least 10% of the consideration received by holders of our common stock consists of consideration that is not common equity, which we refer to as a “cash merger,” then following the cash merger, each holder of a stock purchase contract will have the right to accelerate and settle such stock purchase contract early at the settlement rate in effect immediately prior to the effective date of such transaction, calculated as described below. We refer to this right as the “cash merger settlement right.”

The foregoing paragraph includes a phrase relating to a sale of all or substantially all of our assets. There is no precise, established definition of the phrase “substantially all” under applicable law. Accordingly, your right to accelerate and settle such stock purchase contract early as a result of a sale of substantially all of our assets may be uncertain.

We will provide each of the holders with a notice of the completion of a cash merger within five business days thereof. The notice will specify a cash merger early settlement date, which shall be at least ten business days after the date of the notice but no later than the earlier of 20 business days after the date of such notice or two business days prior to the first day of the next remarketing period, by which each holder’s cash merger settlement right must be exercised. The notice will set forth, among other things, the settlement rate, the stock purchase date for the early settlement and the amount of the cash, securities and other consideration receivable

by the holder upon settlement. To exercise the cash merger settlement right, you must deliver to the stock purchase contract agent, no later than 4:00 p.m., New York City time, on the third business day before the specified cash merger early settlement date, the certificate evidencing your Corporate Units or Treasury Units if they are held in certificated form, and payment of the applicable purchase price in immediately available funds less the amount of any accrued and unpaid contract adjustment payments.

So long as the PEPS Units are evidenced by one or more global securities deposited with the depositary, procedures for early settlement upon a cash merger will also be governed by standing arrangements between the depositary and the stock purchase contract agent.

If you exercise the cash merger settlement right, we will deliver to you on the specified cash merger early settlement date the kind and amount of securities, cash or other property that you would have been entitled to receive if you had settled the stock purchase contract immediately before the effective date of the cash merger and received shares of our common stock at the settlement rate then in effect. The settlement rate then in effect will be the settlement rate described above under “—Purchase of Common Stock,” except that the observation period for determining the applicable market value will be the 20 consecutive trading days ending on the third trading day immediately preceding the effective date of the cash merger. You will also receive the trust preferred securities, junior subordinated debentures, applicable interest in the treasury portfolio or qualifying treasury securities underlying the Corporate Units or Treasury Units, as the case may be. If you do not elect to exercise your cash merger settlement right, your Corporate Units or Treasury Units will remain outstanding and subject to normal settlement on the stock purchase date for equity property units, as defined below under “Anti-dilution Adjustments – Reorganization Events.”

Notice to Settle with Cash

Unless the treasury portfolio has replaced the trust preferred securities as a component of the Corporate Units, a holder of Corporate Units may settle the related stock purchase contract with separate cash by delivering the Corporate Unit certificate, if in certificated form, to the offices of the stock purchase contract agent with the completed “Notice to Settle with Cash” form prior to 5:00 p.m., New York City time, on the second business day immediately preceding the beginning of any remarketing period.

The holder must also deliver to the collateral agent the required cash payment in immediately available funds. Such payment must be delivered prior to 5:00 p.m., New York City time, on the first business day immediately preceding the beginning of a remarketing period.

Upon receipt of the cash payment, the related trust preferred security will be released from the collateral arrangement and transferred to the stock purchase contract agent for distribution to the holder of the related Corporate Units. The holder of the Corporate Units will then receive the applicable number of shares of our common stock on the stock purchase date for such stock purchase contracts.

If a holder of Corporate Units that has given notice of its intention to settle with cash fails to deliver the cash by the applicable time and date specified above, the trust preferred securities underlying such holder’s Corporate Units will automatically be remarketed, or if there is a failed final remarketing (as defined in “—Remarketing”, below) such trust preferred securities will be put to us, as described under “—Remarketing” below.

Any cash received by the collateral agent upon cash settlement will be invested promptly in permitted investments, as defined in the purchase contract and pledge agreement, and an amount equal to $1,000 times the number of stock purchase contracts settled with cash will be paid to us on the stock purchase date for such stock purchase contracts. Any funds received by the collateral agent in respect of the investment earnings from such investments in excess of such amount will be distributed to the stock purchase contract agent for payment to the holders who settled with cash.

Remarketing

Unless a special event redemption or a termination event has occurred, or all the stock purchase contracts have settled early as a result of an early settlement or an early settlement upon a cash merger, or all of the outstanding PEPS Units are held in the form of Treasury Units and none of the holders of the related trust preferred securities has elected to participate in the remarketing, as described under “Description of the Trust Preferred Securities—Remarketing,” or all of the holders of PEPS Units have settled their stock purchase contracts with separate cash, as described above under “—Notice to Settle with Cash,” and none of the holders of the related trust preferred securities has elected to participate in the remarketing, we, through the remarketing agent, will attempt to remarket the trust preferred securities (or, if the junior subordinated debentures are no longer held by the Morgan Stanley Trusts, the junior subordinated debentures) in a process we call “remarketing.” The periods during which a remarketing will be attempted, or “remarketing periods,” will each consist of five consecutive business days beginning on the seventh business day prior to each of August 17, 2010, November 17, 2010, February 17, 2011, May 17, 2011 and August 17, 2011 (or if any such day is not a business day, the immediately succeeding business day) and such remarketings will continue to be attempted until the earlier to occur of the fifth such period or the earlier settlement of a successful remarketing for such series of trust preferred securities (or junior subordinated debentures). A successful remarketing for a series will settle on the date, or “remarketing settlement date,” that is the third business day after the last day of the relevant remarketing period. If a successful remarketing occurs with respect to a series, the stock purchase date related to such series will occur on the remarketing settlement date. For a detailed description of the remarketing procedures, see “Description of the Junior Subordinated Debentures—Remarketing.”

On any day other than the last day of a remarketing period, we will have the right, in our absolute discretion and without prior notice to the holders of the PEPS Units, to postpone the remarketing until the following business day.

If the remarketing agent is unable to remarket a series of trust preferred securities for settlement on or before August 17, 2011 (or if such day is not a business day, the immediately succeeding business day), a “failed final remarketing” will be deemed to have occurred for such series. In that case:

•

If you hold trust preferred securities as a component of Corporate Units, and unless you elect not to exercise your put right by delivering cash to settle your stock purchase contracts, you will be deemed to have elected to apply the put price to satisfy in full your obligations to purchase our common stock under the related stock purchase contracts;

•

We will issue additional subordinated notes in the amount of any accrued and unpaid interest on the junior subordinated debentures (including deferred interest) as of the stock purchase date to Morgan Stanley Trust, which will in turn distribute such notes to the holders of Corporate Units and we will issue additional subordinated notes in the amount of the unpaid contract adjustment payment amount to the stock purchase contract agent for distribution to the holders of the PEPS Units.

We will notify you of any failed remarketings and of a failed final remarketing.

We will covenant in the purchase contract and pledge agreement to use our commercially reasonable efforts to effect the remarketing of the trust preferred securities as described in this offering memorandum.

Contract Adjustment Payments

We will make periodic contract adjustment payments, or “contract adjustment payments,” on the stock purchase contracts at the rate of 3% per annum of the stated amount of $1,000 per stock purchase contract. Contract adjustment payments will be calculated on the basis of a 360-day year consisting of twelve 30-day months. Contract adjustment payments will accrue from the original issue date of the Corporate Units and, subject to our right to defer contract adjustment payments described below, will be payable on each distribution date through the stock purchase date. If any distribution date is not a business day, then payment of

the contract adjustment payments payable on that date will be made on the next business day, and no interest or payment will be paid in respect of the delay.

Contract adjustment payments will be payable to the holders of stock purchase contracts as they appear on the books and records of the stock purchase contract agent at the close of business on the relevant record dates, which will be on the first day of the month in which the relevant distribution date falls. These distributions will be paid through the stock purchase contract agent, who will hold amounts received in respect of the contract adjustment payments for the benefit of the holders of the PEPS Units.

Our obligations with respect to contract adjustment payments will be subordinate and junior in right of payment to our obligations under any of our senior debt to the same extent as the junior subordinated debentures. The stock purchase contracts do not limit our incurrence of indebtedness, including senior debt. No contract adjustment payments may be made if there shall have occurred and be continuing a default in any payment with respect to senior debt or an event of default with respect to any senior debt resulting in the acceleration of the maturity thereof, or if any judicial proceedings are pending with respect to any such default.

Absent a change in law, you and we agree to treat contract adjustment payments on the stock purchase contracts as a purchase price adjustment to the price of the common stock to be purchased under the stock purchase contracts. Notwithstanding the above, we intend to withhold federal income tax with respect to all contract adjustment payments on the stock purchase contracts that are made to any non-U.S. holder of a stock purchase contract, unless such holder is entitled to an exemption from withholding and has provided us with an unexpired, complete and properly executed certification that such holder is exempt from withholding, as required by law.

Option to Defer Contract Adjustment Payments

We may, at our option, and will at the direction of any then applicable regulatory authority, defer contract adjustment payments on the corresponding stock purchase contracts at any time or from time to time. If we defer contract adjustment payments we will provide prior written notice to holders of PEPS Units and the stock purchase contract agent. We may elect to defer contract adjustment payments on more than one occasion. Deferred contract adjustment payments will accrue interest until paid, compounded on each distribution date at the rate of 9% per annum. We may pay any deferred contract adjustment payments and accrued interest thereon in cash on any distribution date following the beginning of the deferral period that falls on or prior to the stock purchase date. Any contract adjustment payments (including any deferred contract adjustment payments and accrued interest thereon), not paid in cash on the stock purchase date will be paid in additional subordinated notes, as described under “Description of the Junior Subordinated Debentures – Option to Defer Interest Payments”. If the stock purchase contracts are terminated upon the occurrence of certain events of bankruptcy, insolvency or reorganization with respect to us, your right to receive contract adjustment payments, including any deferred contract adjustment payments, also will terminate.

If we elect or are directed by any then applicable regulatory authority to defer contract adjustment payments, then, until the deferred contract adjustment payments have been paid in cash or any additional subordinated notes we issue in respect of deferred contract adjustment payments have been repaid in full, we will not make any of the payments that we would be prohibited from making during a deferral of interest payments on the junior subordinated debentures as described under “Description of the Junior Subordinated Debentures—Restrictions on Certain Payments.”

Termination

The purchase contract and pledge agreement provides that the stock purchase contracts and the obligations and rights of us and of the holders of Corporate Units and Treasury Units thereunder (including the holders’ obligation and right to purchase and receive shares of our common stock and to receive accrued and unpaid contract adjustment payments) will immediately and automatically terminate upon the occurrence of certain events of bankruptcy, insolvency or reorganization with respect to Morgan Stanley.

Upon any termination, the collateral agent will release the related interests in the trust preferred securities, applicable ownership interests in the treasury portfolio, or qualifying treasury securities, as the case may be, from the pledge arrangement and transfer such interests in the trust preferred securities, applicable ownership interests in the treasury portfolio or qualifying treasury securities to the purchase contract agent for distribution to the holders of Corporate Units and Treasury Units. If a holder would otherwise have been entitled to receive less than $1,000 principal amount at maturity of any treasury security upon termination of the stock purchase contract, the stock purchase contract agent will dispose of the security for cash and pay cash to the holder. Upon any termination, however, such release and distribution may be subject to a delay. In the event that Morgan Stanley becomes the subject of a case under the U.S. Bankruptcy Code, such delay may occur as a result of the automatic stay under the U.S. Bankruptcy Code and continue until such automatic stay has been lifted. We expect any such delay to be limited. Moreover, claims arising out of the trust preferred securities will be subject to the equitable jurisdiction and powers of the bankruptcy court. For example, although we do not believe such an argument would prevail, following the termination of the stock purchase contracts, a party in interest in the bankruptcy proceeding might argue that the holders of the trust preferred securities should be treated as equity holders, rather than creditors, in the bankruptcy proceeding.

Pledged Securities and the Purchase Contract and Pledge Agreement

Your trust preferred securities, your applicable ownership interest in the treasury portfolio and the qualifying treasury securities, also referred to as the “pledged securities,” will be pledged to the collateral agent for our benefit, pursuant to the purchase contract and pledge agreement, to secure your obligations to purchase shares of our common stock under the stock purchase contracts. Your rights to the pledged securities will be subject to our security interest created by the purchase contract and pledge agreement. The aggregate liquidation amount of pledged trust preferred securities, the principal amount of the applicable ownership interests in the treasury portfolio and the principal amount of the qualifying treasury securities constituting pledged securities, must always equal at least the purchase price of our common stock under the stock purchase contracts. Accordingly, you may not withdraw pledged securities from the pledge arrangement except:

•	to substitute qualifying treasury securities for trust preferred securities in connection with an exchange of Corporate Units for Treasury Units and trust preferred securities, as provided for under “Description of the PEPS Units—Creating Treasury Units”;

•	to substitute trust preferred securities for qualifying treasury securities in connection with an exchange of Treasury Units and trust preferred securities for Corporate Units, as provided for under “Description of the PEPS Units—Recreating Corporate Units”; or

•	upon the termination of the stock purchase contracts.

Subject to the security interest and the terms of the purchase contract and pledge agreement, each holder of Corporate Units will be entitled through the stock purchase contract agent and the collateral agent to all of the proportional rights of the related trust preferred securities, including voting and redemption rights, and their proceeds. Each holder of Treasury Units will retain beneficial ownership of the related qualifying treasury securities pledged in respect of the related stock purchase contracts. We will have no interest other than our security interest in the pledged securities.

Except as described in “Certain Other Provisions of the Purchase Contract and Pledge Agreement,” the collateral agent will, upon receipt, if any, of payments on the pledged securities, distribute the payments to the stock purchase contract agent, which will in turn distribute those payments to the persons in whose names the related PEPS Units are registered at the close of business on the record date immediately preceding the date of payment. Holders of not less than $1 million aggregate stated amount of PEPS Units of a series shall be entitled to receive such payments by wire transfer in immediately available funds on the applicable date of payment.

By acceptance of the PEPS Units, you will be deemed to have:

•	irrevocably agreed to be bound by the terms and provisions of the related stock purchase contracts and the purchase contract and pledge agreement and to have agreed to perform your obligations thereunder for so long as you remain a holder of the PEPS Units, and

•	duly appointed the stock purchase contract agent as your attorney-in-fact to enter into and perform the related stock purchase contracts and pledge agreement on your behalf and in your name.

In addition, as a beneficial owner of the PEPS Units, by acceptance of the beneficial interest therein, you will be deemed to have agreed for all U.S. federal income tax purposes:

•	to treat the acquisition of a PEPS Unit as an acquisition of the related trust preferred security and the related stock purchase contract constituting such PEPS Unit;

•	to allocate 100% of the purchase price of a PEPS Unit to the trust preferred security;

•	to treat yourself as the owner of the stock purchase contracts and the related trust preferred securities, applicable ownership interests in the treasury portfolio or the qualifying treasury securities, as the case may be, and

•	to treat the junior subordinated debentures as our indebtedness for all U.S. federal income tax purposes, which is not subject to the contingent payment debt regulations.

Anti-dilution Adjustments

Each of the fixed settlement rates will be subject to the following adjustments:

(1) Stock Dividends. If we pay or make a dividend or other distribution on all or substantially all of our common stock in common stock, each fixed settlement rate in effect at the opening of business on the day following the date fixed for the determination of stockholders entitled to receive such dividend or other distribution shall be increased by dividing:

�	each fixed settlement rate by

�

a fraction of which the numerator shall be the number of shares of our common stock outstanding at the close of business on the date fixed for such determination and the denominator shall be the sum of such number of shares and the total number of shares constituting such dividend or other distribution.

(2) Stock Purchase Rights. If we issue to all or substantially all holders of our common stock rights, options or warrants entitling them to subscribe for or purchase shares of our common stock for a period expiring within 60 days from the date of issuance of such rights, options or warrants at a price per share of our common stock less than the current market price on the date fixed for the determination of stockholders entitled to receive such rights, options or warrants, each fixed settlement rate in effect at the opening of business on the day following the date fixed for such determination shall be increased by dividing:

�	each fixed settlement rate by

�

a fraction, the numerator of which shall be the number of shares of our common stock outstanding at the close of business on the date fixed for such determination plus the number of shares of our common stock which the aggregate consideration expected to be received by us upon the exercise, or exchange of such rights, options or warrants would purchase at such current market price and the denominator of which shall be the number of shares of our common stock outstanding at the close of business on the date fixed for such determination plus the number of shares of our common stock so offered for subscription or purchase, either directly or indirectly.

(3) Stock Splits; Reverse Splits; and Combinations. If outstanding shares of our common stock shall be subdivided, split or reclassified into a greater number of shares of common stock, each fixed settlement rate in effect at the opening of business on the day following the day upon which such subdivision, split or reclassification becomes effective shall be proportionately increased, and, conversely, in case outstanding shares of our common stock shall each be combined or reclassified into a smaller number of shares of common stock, each fixed settlement rate in effect at the opening of business on the day following the day upon which such combination or reclassification becomes effective shall be proportionately reduced.

(4) Debt, Asset or Security Distributions. If we, by dividend or otherwise, distribute to all or substantially all holders of our common stock evidences of our indebtedness, assets or securities (but excluding any rights, options or warrants referred to in paragraph (2) above, any dividend or distribution paid exclusively in cash referred to in paragraph (5) below or any dividend of shares of capital stock of any class or series, or similar equity interests, of or relating to a subsidiary or other business unit in the case of a spin-off referred to below, or any dividend or distribution referred to in paragraph (1) above), each fixed settlement rate in effect immediately prior to the close of business on the date fixed for the determination of stockholders entitled to receive such distribution shall be increased by dividing:

�	each fixed settlement rate by

�

a fraction, the numerator of which shall be the current market price on the date fixed for such determination less the then fair market value of the portion of the assets or evidences of indebtedness so distributed applicable to one share of our common stock and the denominator of which shall be such current market price.

In the case of the payment of a dividend or other distribution on our common stock of shares of capital stock of any class or series, or similar equity interests, of or relating to a subsidiary or other business unit of ours, which we refer to as a “spin-off,” each fixed settlement rate in effect immediately before the close of business on the record date fixed for determination of stockholders entitled to receive that distribution will be increased by dividing:

�	each fixed settlement rate by

�

a fraction, the numerator of which is the average VWAP over the 10 trading days from and including the third trading day after the date on which “ex-distribution trading” commences for such dividend or distribution on the NYSE or such other national or regional exchange or market on which our common stock is then listed or quoted, except as described below, and the denominator of which is such average VWAP plus the fair market value, determined as described below, of those shares of capital stock or similar equity interests so distributed applicable to one share of common stock.

The adjustment to each fixed settlement rate under the preceding paragraph will occur on the date that is the earlier of:

�	the close of business on the 10th trading day after the third trading day after the date on which “ex-distribution trading” commences for such dividend or distribution on the NYSE or such other national or regional exchange or market on which our common stock is then listed or quoted; and

�	the date of the securities being offered in the initial public offering of the spin-off, if that initial public offering is effected simultaneously with the spin-off.

For purposes of this section, “initial public offering” means the first time securities of the same class or type as the securities being distributed in the spin-off are offered to the public for cash.

In the event of a spin-off that is not effected simultaneously with an initial public offering of the securities being distributed in the spin-off, the fair market value of the securities to be distributed to holders of our

common stock means the average VWAP of those securities over the first 10 trading days from and including the third trading day after the date on which trading commences for such securities on the NYSE or such other national or regional exchange or market on which such securities are then listed or quoted.

If, however, an initial public offering of the securities being distributed in the spin-off is to be effected simultaneously with the spin-off, the fair market value of the securities being distributed in the spin-off means the initial public offering price, while the current market price of our common stock means the VWAP of our common stock on the trading day on which the initial public offering price of the securities being distributed in the spin-off is determined.

(5) Cash Distributions. If we, by dividend or otherwise, make distributions to all or substantially all holders of our common stock exclusively in cash during any quarterly period (excluding any cash that is distributed in a reorganization event to which the provisions described below under “—Reorganization Events” apply or as part of a distribution referred to in paragraph (4) above) in an amount that exceeds $0.27 per share per quarter of our common stock (such per share amount being referred to at the “reference dividend”), immediately after the close of business on the date fixed for determination of the stockholders entitled to receive such distribution, each fixed settlement rate shall be increased by dividing:

�	each fixed settlement rate by

�	a fraction, the numerator of which shall be equal to the current market price on the date fixed for such determination less the per share amount of the distribution and the denominator of which shall be equal to such current market price minus the reference dividend.

The reference dividend is subject to adjustment on an inversely proportional basis whenever the fixed settlement rates are adjusted, provided that no adjustment will be made to the reference dividend for any adjustment made to the fixed settlement rates pursuant to this clause (5).

(6) Tender and Exchange Offers. In the case that a tender offer or exchange offer made by us or any subsidiary for all or any portion of our common stock shall expire and such tender or exchange offer (as amended through the expiration thereof) shall require the payment to stockholders (based on the acceptance (up to any maximum specified in the terms of the tender offer or exchange offer) of purchased shares) of an aggregate consideration having a fair market value per share of our common stock that exceeds the VWAP on the trading day next succeeding the last date on which tenders or exchanges may be made pursuant to such tender offer or exchange offer, then, immediately prior to the opening of business on the second business day after the date of the last time (which we refer to as the “expiration time”) tenders or exchanges could have been made pursuant to such tender offer or exchange offer (as amended through the expiration thereof), each fixed settlement rate shall be increased by dividing:

�	each fixed settlement rate immediately prior to the close of business on the date of the expiration time by

�

a fraction (A) the numerator of which shall be equal to (x) the product of (i) the current market price on the date of the expiration time and (ii) the number of shares of common stock outstanding (including any tendered or exchanged shares) on the date of the expiration time less (y) the amount of cash consideration plus the fair market value of the aggregate non-cash consideration payable to stockholders pursuant to the tender offer or exchange offer (assuming the acceptance, up to any maximum specified in the terms of the tender offer or exchange offer, of purchased shares), and (B) the denominator of which shall be equal to the product of (x) the current market price on the date of the expiration time and (y) the result of (i) the number of shares of our common stock outstanding (including any tendered or exchanged shares) on the date of the expiration time less (ii) the number of all shares validly tendered, not withdrawn and accepted for payment on the date of the expiration time (such validly tendered or exchanged shares, up to any such maximum, being referred to as the “purchased shares”).

The “current market price” per share of our common stock or any other security on any day means the average VWAP for the 20 consecutive trading days preceding the earlier of the day preceding the day in question and the day before the “ex date” with respect to the issuance or distribution requiring such computation. For purposes of this paragraph, the term “ex date,” when used with respect to any issuance or distribution, means the first date on which our common stock or such other security, as applicable, trades, regular way, on the principal U.S. securities exchange or quotation system on which our common stock or such other security, as applicable, is listed or quoted at that time, without the right to receive the issuance or distribution.

Reorganization Events. The following events are defined as “reorganization events”:

�	any consolidation or merger of Morgan Stanley with or into another person or of another person with or into Morgan Stanley; or

�	any sale, transfer, lease or conveyance to another person of the property of Morgan Stanley as an entirety or substantially as an entirety; or

�	any statutory share exchange of Morgan Stanley with another person (other than in connection with a merger or acquisition); or

�	any liquidation, dissolution or termination of Morgan Stanley

in each case in which holders of our common stock would be entitled to receive cash, securities or other property for their shares of common stock.

Upon a reorganization event, each stock purchase contract shall thereafter, in lieu of a variable number of shares of our common stock, be settled by delivery of exchange property units. An “exchange property unit” represents the right to receive the kind and amount of securities, cash and other property receivable in such reorganization event (without any interest thereon, and without any right to dividends or distribution thereon which have a record date that is prior to the applicable settlement date) per share of our common stock by a holder of common stock that is not a person with which we are consolidated or into which we are merged or which merged into us or to which such sale or transfer was made, as the case may be (we refer to any such person as a “constituent person”), or an affiliate of a constituent person to the extent such reorganization event provides for different treatment of common stock held by our affiliates and non-affiliates. In the event all holders of our common stock (other than any constitutent person and affiliates thereof) do not receive the same form of consideration to be received in such transaction, the exchange property unit that holders of the Corporate Units or Treasury Units will be entitled to receive will be deemed to be the weighted average of the types and amounts of consideration received by the holders of our common stock that affirmatively make an election (or of all such holders if none make an election).

In the event of such a reorganization event, the person formed by such consolidation, or merger or the person which acquires our assets shall execute and deliver to the transfer agent an agreement providing that the holder of each PEPS Unit that remains outstanding after the reorganization event (if any) shall have the rights described in the preceding paragraph. Such supplemental agreement shall provide for adjustments to the amount of any securities constituting all or a portion of an exchange property unit which, for events subsequent to the effective date of such reorganization event, shall be as nearly equivalent as may be practicable to the adjustments provided for in this “—Anti-dilution Adjustments” section. The provisions described in the preceding two paragraphs shall similarly apply to successive reorganization events.

Holders have the right to settle their obligations under the PEPS Units early in the event of certain cash mergers as described above under “—Early Settlement Upon Cash Merger.”

You may be treated as receiving a constructive distribution from us with respect to the stock purchase contract if under applicable Treasury regulations (1) the settlement rate is adjusted (or fails to be adjusted) and,

as a result of the adjustment (or failure to adjust), your proportionate interest in our assets or earnings and profits is increased, and (2) the adjustment (or failure to adjust) is not made pursuant to a bona fide, reasonable anti-dilution formula. Thus, under certain circumstances, an increase in (or a failure to decrease) the settlement rate might give rise to a taxable dividend to you even though you will not receive any cash in connection with the increase in (or failure to decrease) the settlement rate. In addition, non-U.S. holders of PEPS Units may, in certain circumstances, be deemed to have received a distribution subject to U.S. federal withholding tax.

In addition, we may increase the settlement rate if our board of directors deems it advisable to avoid or diminish any income tax to holders of our common stock resulting from any dividend or distribution of shares (or rights to acquire shares) or from any event treated as a dividend or distribution for income tax purposes or for any other reasons.

Adjustments to the settlement rate will be calculated to the nearest 1/10,000th of a share. No adjustment in the settlement rate will be required unless the adjustment would require an increase or decrease of at least one percent in the settlement rate. If any adjustment is not required to be made because it would not change the settlement rate by at least one percent, then the adjustment will be carried forward and taken into account in any subsequent adjustment, provided that effect shall be given to anti-dilution adjustments not later than the stock purchase date for a PEPS Unit.

No adjustment to the settlement rate need be made if holders may participate in the transaction that would otherwise give rise to an adjustment, so long as the distributed assets or securities the holders would receive upon settlement of the PEPS Units, if convertible, exchangeable, or exercisable, are convertible, exchangeable or exercisable, as applicable, without any loss of rights or privileges for a period of at least 60 days following settlement of the PEPS Units.

The fixed settlement rates will not be adjusted:

�	upon the issuance of any shares of our common stock pursuant to any present or future plan providing for the reinvestment of dividends or interest payable on our securities and the investment of additional optional amounts in shares of our common stock under any plan;

�	upon the issuance of any shares of our common stock or options or rights to purchase those shares pursuant to any present or future employee, director or consultant benefit plan or program of or assumed by us or any of our subsidiaries;

�	upon the issuance of any shares of our common stock pursuant to any option, warrant, right or exercisable, exchangeable or convertible security outstanding as of the date the PEPS Units were first issued;

�	for a change in the par value or no par value of the common stock; or

�	for accumulated and unpaid dividends.

We will be required, as soon as practicable after the settlement rate is adjusted, to provide written notice of the adjustment to the holders of PEPS Units.

If an adjustment is made to each fixed settlement rate pursuant to paragraphs (1) through (6) of this “— Anti-dilution Adjustments” section, a corresponding adjustment also will be made to the applicable market value solely to determine which of the clauses of the definition of settlement rate will be applicable on the stock purchase date or any cash merger early settlement date, but there will be no adjustment to the applicable market value as such term is used as the denominator in the fraction described in clause (2) of the definition of settlement rate set forth in “— Purchase of Common Stock,” provided that if an event requiring an adjustment occurs on any trading day during the observation period, the VWAP calculated for each trading day before the

event requiring an adjustment occurs will be adjusted in a manner inversely proportional to the adjustment to the fixed settlement rates.

To the extent that we have a rights plan in effect upon a settlement of a purchase contract, you will receive, in addition to our common stock, the rights under the rights plan, unless, prior to the settlement of a purchase contract, the rights have separated from the common stock, in which case each fixed settlement rate will be adjusted at the time of separation as if we made a distribution to all holders of our common stock as described in clause (4) above, subject to readjustment in the event of the expiration, termination or redemption of such rights.

CERTAIN OTHER PROVISIONS OF THE PURCHASE CONTRACT AND PLEDGE AGREEMENT

The following is a summary of certain other provisions of the purchase contract and pledge agreement. This summary, together with the summary of some of the provisions of the related documents described below, contains a description of certain other provisions of the purchase contract and pledge agreement but is not necessarily complete.

No Consent to Assumption

Holders of PEPS Units, by acceptance of PEPS Units, will under the terms of the purchase contract and pledge agreement for the relevant series of PEPS Units expressly withhold any consent to the assumption (i.e., affirmance) of the stock purchase contracts and the PEPS Units, as applicable, by us or our trustee if we become the subject of a case under the U.S. Bankruptcy Code or other similar state or federal law provision for reorganization or liquidation.

Consolidation, Merger, Sale or Conveyance

We covenant in the purchase contract and pledge agreement for a series of PEPS Units that we will not merge or consolidate with, or transfer or lease all or substantially all of our assets to, any person or entity, unless:

•	we will be the continuing corporation; or

•	the successor corporation or person that acquires all or substantially all of our assets:

�	will be a corporation organized under the laws of the United States, a state of the United States or the District of Columbia; and

�	will expressly assume all of our obligations under the stock purchase contracts, the purchase contract and pledge agreement, the trust agreement, the junior subordinated indenture, the junior subordinated debentures, the guarantee and the remarketing agreement; and

•

immediately after the merger, consolidation, sale, lease or conveyance, we, that person or that successor corporation will not be in default in the performance of the covenants and conditions applicable to us under the stock purchase contracts, the purchase contract and pledge agreement, the trust agreement, the junior subordinated indenture, the junior subordinated debentures, the guarantee or the remarketing agreement.

Modification

Each purchase contract and pledge agreement will contain provisions permitting us, the stock purchase contract agent or the collateral agent, as the case may be, to modify the purchase contract and pledge agreement without the consent of the holders for any of the following purposes:

•	to evidence the succession of another person to our obligations,

•	to add to the covenants for the benefit of holders or to surrender any of our rights or powers under those agreements,

•	to evidence and provide for the acceptance of appointment of a successor stock purchase contract agent or a successor collateral agent or securities intermediary,

•	to cure any ambiguity or to correct or supplement any provisions that may be inconsistent, and

•	to make any other modifications that do not adversely affect the interest of the holders in any material respect.

Each purchase contract and pledge agreement will contain provisions permitting us and the stock purchase contract agent and the collateral agent, with the consent of the holders of not less than a majority of the stock purchase contracts included in the relevant series of PEPS Units at the time outstanding, to modify the terms of such stock purchase contracts or such purchase contract and pledge agreement. However, no such modification may, without the consent of the holder of each outstanding stock purchase contract affected by the modification,

•	change any distribution date,

•	change the amount or type of pledged securities related to the stock purchase contract, impair the right of the holder of any pledged securities to receive distributions on the pledged securities or otherwise adversely affect the holder's rights in or to the pledged securities,

•	reduce any contract adjustment payments or change the place or currency of payment,

•	impair the right to institute suit for the enforcement of the stock purchase contract or payment of any contract adjustment payments,

•

reduce the number of shares of our common stock purchasable under the stock purchase contract, increase the price to purchase shares of our common stock upon settlement of the stock purchase contract or change the stock purchase date (except as contemplated by the purchase contract and pledge agreement), or

•	reduce the above-stated percentage of outstanding stock purchase contracts the consent of the holders of which is required for the modification or amendment of the provisions of the stock purchase contracts or the purchase contract and pledge agreement.

If any amendment or proposal referred to above would adversely affect only the Corporate Units or the Treasury Units of a series of PEPS Units, then only the affected class of holders will be entitled to vote on the amendment or proposal, and the amendment or proposal will not be effective except with the consent of the holders of not less than a majority of the affected class or of all of the holders of the affected classes, as applicable.

Title

We, the stock purchase contract agent and the collateral agent may treat the registered owner of any PEPS Units as the absolute owner of the PEPS Units for the purpose of making payment and settling the related stock purchase contracts and for all other purposes.

Replacement of Certificates

The PEPS Units will be issued initially in certificated, registered form. Any mutilated PEPS Unit certificate will be replaced by us at the expense of the holder upon surrender of the certificate to the stock purchase contract agent. PEPS Unit certificates that become destroyed, lost or stolen will be replaced by us at the expense of the holder upon delivery to us and the stock purchase contract agent of evidence of their destruction, loss or theft satisfactory to us and the stock purchase contract agent. In the case of a destroyed, lost or stolen PEPS Unit certificate, an indemnity satisfactory to the stock purchase contract agent and us may be required at the expense of the holder of the PEPS Units evidenced by the certificate before a replacement will be issued.

Notwithstanding the foregoing, we will not be obligated to issue any PEPS Unit certificates on or after the business day immediately preceding the earliest of any early settlement

date, any cash merger early settlement date, the stock purchase date for any stock purchase contracts or after the stock purchase contracts have terminated. The purchase contract and pledge agreement will provide that, in lieu of the delivery of a replacement PEPS Unit certificate following any of these dates, the stock purchase contract agent, upon delivery of the evidence and indemnity described above, will deliver the shares of our common stock issuable pursuant to the stock purchase contracts included in the PEPS Units evidenced by the certificate or, if the stock purchase contracts have terminated prior to the stock purchase date, transfer the pledged securities included in the PEPS Units evidenced by the certificate.

Information Concerning the Stock Purchase Contract Agent

The Bank of New York initially will be the stock purchase contract agent under each purchase contract and pledge agreement. The stock purchase contract agent will act as the agent for the holders of each series of PEPS Units from time to time. The purchase contract and pledge agreement will not obligate the stock purchase contract agent to exercise any discretionary powers in connection with a default under the terms of the PEPS Units or the purchase contract and pledge agreement.

Each purchase contract and pledge agreement will contain provisions limiting the liability of the stock purchase contract agent. Each purchase contract and pledge agreement will contain provisions under which the stock purchase contract agent may resign or be replaced. Any such resignation or replacement would be effective upon the acceptance of appointment by a successor.

Information Concerning the Collateral Agent and Securities Intermediary

The Bank of New York initially will be the collateral agent and securities intermediary under the purchase contract and pledge agreements.

In its capacity as collateral agent, The Bank of New York will act solely as our agent and will not assume any obligation or relationship of agency or trust for or with any of the holders of the PEPS Units, except for the obligations owed by a pledgee of property to the owner of the property under the relevant purchase contract and pledge agreement and applicable law.

All property delivered to the securities intermediary pursuant to each purchase contract and pledge agreement will be credited to a collateral account established by the securities intermediary for the collateral agent. The securities intermediary will treat the stock purchase contract agent as entitled to exercise all rights relating to any financial asset credited to such collateral account, subject to the provisions of such purchase contract and pledge agreement.

Each purchase contract and pledge agreement will contain provisions limiting the liability of the collateral agent and securities intermediary and provisions under which they may resign or be replaced. This resignation or replacement would be effective upon the acceptance of appointment by a successor.

Governing Law

Each purchase contract and pledge agreement and the stock purchase contracts will be governed by, and construed in accordance with, the laws of the State of New York.

Miscellaneous

Should you elect to substitute the related pledged securities, create Treasury Units or recreate Corporate Units, you will be responsible for any commissions, fees or other expenses incurred in acquiring the pledged securities to be substituted, and we will not be responsible for any of those fees or expenses.

Each purchase contract and pledge agreement will provide that we will pay all fees and expenses related to the offering of the relevant series of PEPS Units, including the fees and expenses of the stock purchase contract

agent and the fees and expenses relating to the enforcement by the stock purchase contract agent of the rights of the holders of the PEPS Units of such series.

Each purchase contract and pledge agreement will provide that we will pay all fees and expenses related to the retention of the collateral agent and securities intermediary.

DESCRIPTION OF THE MORGAN STANLEY CAPITAL TRUSTS

Morgan Stanley Capital Trust A, Morgan Stanley Capital Trust B and Morgan Capital Trust C (each a “Morgan Stanley Trust” and collectively, the “Morgan Stanley Trusts”) will be formed as Delaware statutory trusts. The Morgan Stanley Trusts will exist solely to:

•	issue and sell their common securities to Morgan Stanley;

•	issue and sell their trust preferred securities as part of this offering;

•	use the proceeds from the sale of their common securities and trust preferred securities to purchase junior subordinated debentures from Morgan Stanley; and

•	engage in other activities that are necessary, convenient or incidental to these purposes.

The name and address of the Delaware trustee for each Morgan Stanley Trust will be The Bank of New York (Delaware), White Clay Center, Route 273, Newark, Delaware 19711, and the name and address of the property trustee, the guarantee trustee and the indenture trustee for each Morgan Stanley Trust will be The Bank of New York, 101 Barclay Street, Floor 8 West, New York, New York 10286. The principal offices and telephone number of each Morgan Stanley Trust are 1585 Broadway, New York, New York 10036 and (212) 761-4000.

We, as holder of the common securities of each Morgan Stanley Trust, intend to select our employees, officers or affiliates to serve as administrators of the Morgan Stanley Trusts. Only we, as direct or indirect owner of the common securities, can remove or replace the administrators. In addition, we can increase or decrease the number of administrators. Also, we, as direct or indirect holder of the common securities of the Morgan Stanley Trusts, will generally have the sole right to remove or replace the property trustee and Delaware trustee. However, if a default with respect to the junior subordinated debentures occurs, then, so long as that default is continuing, the holders of a majority in liquidation amount of the outstanding trust preferred securities of the Morgan Stanley Trusts may remove and replace the property trustee and Delaware trustee for the Morgan Stanley Trusts at any time.

We will pay all fees and expenses related to the organization of each Morgan Stanley Trust and the offering of the trust preferred securities. We will also pay all ongoing costs and expenses of the Morgan Stanley Trusts, except obligations under the common securities and trust preferred securities.

DESCRIPTION OF THE TRUST PREFERRED SECURITIES

The following is a summary of some of the terms of the trust preferred securities. This summary, together with the summary of some of the provisions of the related documents described below, contains a description of the material terms of the trust preferred securities but is not necessarily complete.

General

The Morgan Stanley Trusts will issue the trust preferred securities under the terms of the trust agreements. The trust agreements will be deemed to be qualified under the Trust Indenture Act. The Bank of New York will act as the property trustee for purposes of complying with the Trust Indenture Act. The terms of the trust preferred securities will include those stated in the trust agreements and the Delaware Statutory Trust Act and those made part of the trust agreements by the Trust Indenture Act.

The trust preferred securities will have an initial stated amount of $1,000 per trust preferred security and will be mandatorily redeemable for their liquidation amount upon the redemption or maturity of the related junior subordinated debentures (initially February 17, 2042, but subject to change as described below under “—Redemption”).

The trust preferred securities will rank equal to, and payments will be made on the trust preferred securities on a proportional basis with, the common securities, as such term is described under “The Morgan Stanley Capital Trusts.” However, the trust preferred securities will rank prior to the common securities as to payment if there occurs with respect to the junior subordinated debentures an event of default or a default as a result of a failure to pay amounts under the junior subordinated debentures when due as described under “Description of Trust Preferred Securities—Liquidation Distribution Upon Dissolution.” Please note, however, that the aggregate liquidation amount of the common securities for each Morgan Stanley Trust is only $10,000. The trust agreements do not permit the Morgan Stanley Trusts to issue any securities other than the common securities and the trust preferred securities or to incur any indebtedness.

Morgan Stanley will register each series of the junior subordinated debentures in the name of the applicable Morgan Stanley Trust. The property trustee will hold the junior subordinated debentures in trust for the benefit of the holders of the trust preferred securities and the common securities.

Distributions

Subject to the deferral provisions described below, interest on each series of the junior subordinated debentures, and, accordingly, distributions on the related trust preferred securities, will be cumulative and will be fixed initially at an annual rate of 6% of the stated amount. Distributions on the trust preferred securities will accumulate from the date of issuance of the PEPS Units and will be payable quarterly in arrears on each February 17, May 17, August 17 and November 17 occurring prior to and including the date of a successful remarketing, commencing February 17, 2008, and when, as and if funds are available for distributions. We may, however, in connection with a successful remarketing, elect to change the distribution dates effective from and after the remarketing settlement date, including an election to pay distributions semi-annually.

The rate on any series of junior subordinated debentures will be reset in connection with the remarketing of such series as described below under “Description of the Junior Subordinated Debentures—Remarketing.” In addition, the frequency of interest payments of any series of junior subordinated debentures may be changed in connection with the remarketing of any series of trust preferred securities as described under “Description of the Junior Subordinated Debentures—Remarketing.”

We may at our option, and will if so directed by any then applicable regulatory authority, defer cash payments of interest on any series of junior subordinated debentures at any time or from time to time provided that we will not defer cash payments of interest with respect to any series of junior subordinated debentures without deferring cash payments of interest with respect to all remaining series of junior subordinated debentures. We may not defer interest payments with respect to any series of junior subordinated debentures

for any period of time that (i) exceeds 20 consecutive interest payment dates (or the equivalent if interest periods are not at the time quarterly), or (ii) extends beyond the stated maturity date or any redemption date of such series of junior subordinated debentures. Any deferred payments of interest will accrue additional interest at the applicable rate then borne by such series of junior subordinated debentures. As a consequence, each Morgan Stanley Trust will accumulate corresponding distributions on the related series of trust preferred securities. Accumulated distributions will accumulate as interest on the junior subordinated debentures, from the relevant distribution date during any deferral period, at the rate originally applicable to the junior subordinated debentures compounded on each distribution date with respect to the trust preferred securities, to the extent permitted by applicable law.

We covenant that, if, with respect to any series of junior subordinated debentures, we defer interest on any interest payment date on or prior to the stock purchase date for such series, we will notify any then applicable regulatory authority and, if we have elected to defer interest with respect to a series of junior subordinated debentures and there is a failed final remarketing with respect to such series, then we will pay the holders the deferred interest in additional subordinated notes, which will be distributed by the relevant Morgan Stanley Trust to the holders of the related series of trust preferred securities. If we issue any additional subordinated notes, the foregoing covenant will also apply to the payment of interest on and principal of these notes.

After we give notice of any deferral of contract adjustment payments or interest on any series of junior subordinated debentures and during any period that we are deferring interest on such series of junior subordinated debentures (and, accordingly, the relevant Morgan Stanley Trust is accumulating distributions on the related series of trust preferred securities) or have issued but not yet repaid in full additional subordinated notes in respect of deferred interest, we will be restricted, subject to certain exceptions, from making certain payments, including declaring or paying any dividends or making any distributions on, or redeeming, purchasing, acquiring or making a liquidation payment with respect to, shares of our capital stock, as described under “Description of the Junior Subordinated Debentures—Restrictions on Certain Payments.”

Each Morgan Stanley Trust will make distributions on the related series of trust preferred securities on the relevant distribution dates to the extent that it has funds available therefor. The trust funds available for distribution to you as a holder of a series of trust preferred securities will be limited to payments received from us on the related series of junior subordinated debentures held by each Morgan Stanley Trust. We will guarantee the payment of distributions on the trust preferred securities out of moneys held by the relevant Morgan Stanley Trust to the extent of available trust funds held by the applicable Morgan Stanley Trust, as described under “Description of the Guarantee.” Our obligations under the junior subordinated debentures are subordinate and junior in right of payment to all our senior debt.

When a distribution date is not a business day, the Morgan Stanley Trusts will make the distribution on the next business day without interest. The term “distribution” includes any interest payable on unpaid distributions unless otherwise stated.

Distributions made for periods prior to the stock purchase date will be calculated on the basis of a 360-day year consisting of twelve 30-day months, and distributions for periods beginning on or after such date will be calculated on the same basis as the reset interest rate on the junior subordinated debentures is calculated.

Payment of Distributions

Distributions on the trust preferred securities will be payable to holders, including the collateral agent, as they appear on the books and records of the Morgan Stanley Trusts on the relevant record dates. The record dates will be the first day of the month in which the relevant distribution date falls.

The Morgan Stanley Trusts will pay distributions through the property trustee. The property trustee will hold amounts received from the junior subordinated debentures in the payment account for the benefit of the holders of the related series of trust preferred securities and the related series of common securities.

If a distribution is payable on a day that is not a business day, then that distribution will be paid on the next day that is a business day, and without any interest or other payment for any delay, with the same force and effect as if made on the distribution date.

A business day is a day other than (a) a Saturday or Sunday, and (b) a day on which banking institutions in The City of New York, New York are authorized or required by law or executive order to close.

Remarketing

Unless a special event redemption or a termination event has occurred, or all the stock purchase contracts have settled early as a result of an early settlement or an early settlement upon a cash merger, or all of the outstanding PEPS Units are held in the form of Treasury Units and none of the holders of the related trust preferred securities has elected to participate in the remarketing, as described under “Description of the Trust Preferred Securities—Remarketing,” or all of the holders of PEPS Units have settled their stock purchase contracts with separate cash, as described above under “—Notice to Settle with Cash,” and none of the holders of the related trust preferred securities have elected to participate in the remarketing, we, through the remarketing agent, will attempt to remarket the trust preferred securities in a process we call “remarketing.” All of the outstanding trust preferred securities held as part of Corporate Units will be remarketed in the remarketing other than those the holders of which have elected (i) not to participate in the remarketing and (ii) to settle the related stock purchase contract with separate cash, whether or not the remarketing is successful. See “Description of the Stock Purchase Contracts—Notice to Settle with Cash.” If you hold trust preferred securities separately and not as part of the Corporate Units, your trust preferred securities will not be remarketed unless you elect to participate in the remarketing. After any successful remarketing, the interest rate, interest payment dates and other terms of each series of the underlying junior subordinated debentures may change, as a result of which the distribution rate on and certain other terms of all of the related trust preferred securities may also change, even those that were not included in the remarketing. See “Description of the Junior Subordinated Debentures—Remarketing.”

Under the remarketing agreement, on or prior to 5:00 p.m., New York City time, on the second business day immediately preceding the beginning of any remarketing period holders of the trust preferred securities not held as part of the related series of Corporate Units may elect to have their trust preferred securities included in the remarketing and remarketed in the same manner and at the same price as the trust preferred securities held as part of the Corporate Units by delivering their trust preferred securities along with a notice to the collateral agent. The collateral agent will hold these trust preferred securities or their proceeds, as the case may be, in an account separate from the collateral account in which the securities pledged to secure the obligations of the holders of Corporate Units under the stock purchase contracts will be held. Holders of the trust preferred securities electing to have their trust preferred securities remarketed will also have the right to withdraw that election on or prior to 5:00 p.m., New York City time, on the second business day immediately preceding the beginning of any remarketing period. If the remarketing agent cannot remarket a series of trust preferred securities during any remarketing period, the remarketing agent will promptly return such trust preferred securities not held as part of Corporate Units to the collateral agent for release to the holders.

If the remarketing of any series of trust preferred securities is successful, the remarketing agent will remit to the collateral agent the proceeds of such remarketing for payment to such participating holders of trust preferred securities not held as part of Corporate Units.

Redemption

When Morgan Stanley repays or redeems a series of the junior subordinated debentures, whether at the final maturity date or upon earlier redemption, the property trustee will apply the proceeds from the repayment or redemption to redeem the related trust preferred securities and common securities having an aggregate liquidation amount equal to that portion of the principal amount of such series of junior subordinated debentures being repaid or redeemed. The redemption price per trust preferred security will equal the $1,000 liquidation amount, plus accrued and unpaid distributions to but excluding the redemption date for such trust

preferred securities, provided that, in the case of an early redemption in connection with a special event (as defined below), the redemption price per security will be the redemption amount determined as described below plus the amount of deferred interest (including compound interest thereon) through the date of redemption.

In the case of an early redemption in connection with a special event prior to the remarketing settlement date for a series of trust preferred securities, the redemption price payable in respect of all junior subordinated debentures included in PEPS Units of the related series will be distributed to the collateral agent, which in turn will apply an amount equal to the redemption amount (as defined below) of such redemption price to purchase the treasury portfolio on behalf of the holders of the PEPS Units of such series and remit the remaining portion (net of fees and expenses, if any), if any, of such redemption price to the stock purchase contract agent for payment to the holders of such series of PEPS Units. Thereafter, the applicable ownership interests in the treasury portfolio will be substituted for such series of junior subordinated debentures and will be pledged to us through the collateral agent to secure the related PEPS Unit holders’ obligations to purchase shares of our common stock under the related stock purchase contracts. Holders of junior subordinated debentures of such series that are not part of PEPS Units will directly receive proceeds from the redemption of the junior subordinated debentures.

If less than all of the junior subordinated debentures of a series are to be repaid or redeemed, then the aggregate liquidation amount of the related trust preferred securities and related common securities to be redeemed will be allocated in proportion to their respective aggregate liquidation amounts, except in the case of an event of default or a default under such junior subordinated debentures as a result of any failure by Morgan Stanley to pay any amounts under such junior subordinated debentures when due. Please note, however, that the aggregate liquidation amount of the common securities of each Morgan Stanley Trust is only $10,000.

Subject to obtaining any then required regulatory approval, Morgan Stanley may redeem the junior subordinated debentures included in a series of Corporate Units:

�

in whole or in part, on one or more occasions, at any time on or after the date (the “first optional redemption date” that is the later of (a) August 17, 2012 if the relevant stock purchase date is on August 17, 2010 (or if such day is not a business day, the next succeeding business day) and the third anniversary of the relevant stock purchase date if such date is after August 17, 2010 (or if such day is not a business day, the next succeeding business day) and (b) if we are deferring interest on the related junior subordinated debentures on the applicable stock purchase date, the date that is five years after the beginning of the relevant deferral period; and

�	in whole, but not in part, at any time prior to the remarketing settlement date for the related series of trust preferred securities:

�	within 90 days following the occurrence and continuation of a tax event, accounting event or an investment company event, each as defined below,

�	following the occurrence and continuation of a regulatory event, rating agency event or property trustee event, each as defined below.

If then required under the rules and regulations of any applicable regulatory authority, Morgan Stanley will obtain the prior approval of such applicable regulatory authority before exercising its redemption rights described in this offering memorandum.

A redemption of the junior subordinated debentures will cause a mandatory redemption of the related series of the trust preferred securities and the common securities. See “Description of Junior Subordinated Debentures—Redemption.”

“Special event” means a tax event, an accounting event, an investment company event, a regulatory event, a rating agency event or a property trustee event.

“Tax event” means the receipt by Morgan Stanley of an opinion of counsel experienced in such matters, who is not an officer or employee of Morgan Stanley or any of its affiliates, to the effect that as a result of:

�	any amendment to, or change, including any announced prospective change, in the laws, or any regulations thereunder, of the United States or any political subdivision thereof or taxing authority therein affecting taxation which is effective on or after the date of this offering memorandum;

�	any official or administrative pronouncement or action or judicial decision interpreting or applying such laws or regulations which is announced on or after the date of this offering memorandum; or

�

any threatened challenge asserted in connection with an audit of a Morgan Stanley Trust, Morgan Stanley or Morgan Stanley’s subsidiaries, or a threatened challenge asserted in writing against any other taxpayer that has raised capital through the issuance of securities that are substantially similar to the junior subordinated debentures or the PEPS Units, which challenge becomes publicly known or otherwise becomes widely known to tax practitioners on or after the date of this offering memorandum;

there is more than an insubstantial increase in the risk that:

(1)

a Morgan Stanley Trust is, or will be within 90 days of the delivery of the opinion of counsel, subject to U.S. federal income tax with respect to income received or accrued on the junior subordinated debentures;

(2)

interest payable by Morgan Stanley on the junior subordinated debentures is not, or will not be within 90 days of the delivery of the opinion of counsel, deductible by Morgan Stanley, in whole or in part, for U.S. federal income tax purposes; or

(3)

a Morgan Stanley Trust is, or will be within 90 days of the delivery of the opinion of counsel, subject to more than a de minimis amount of taxes, duties or other governmental charges.

If any Morgan Stanley Trust is the holder of all the junior subordinated debentures and any of the events referred to in clause (1) or (3) above shall occur, Morgan Stanley will pay any additional sums required so that distributions on the trust preferred securities will not be reduced by any additional taxes, duties or other governmental charges payable by such Morgan Stanley Trust as a result of the tax event. See “Description of Junior Subordinated Debentures—Additional Sums.”

“Accounting event” means the receipt by the audit committee of our Board of Directors of a written report in accordance with Statement on Auditing Standards (“SAS”) No. 97, “Amendment to SAS No. 50— Reports on the Application of Accounting Principles,” from our independent auditors, provided at the request of management, to the effect that, as a result of a change in accounting rules after the date of original issuance of the junior subordinated debentures, we must either (a) account for the stock purchase contracts as derivatives under SFAS 133 (or otherwise mark-to-market or measure the fair value of all or any portion of the stock purchase contracts with changes appearing in our income statement) or (b) account for PEPS Units using the if-converted method under SFAS 128, and that such accounting treatment will cease to apply upon redemption of the relevant series of junior subordinated debentures.

“Investment company event” means the receipt by Morgan Stanley of an opinion of counsel experienced in such matters, who is not an officer or employee of Morgan Stanley or any of its affiliates, to the effect that, as a result of the occurrence of a change in law or regulation or a written change, including any announced prospective change, in interpretation or application of law or regulation by any legislative body, court, governmental agency or regulatory authority, there is more than an insubstantial risk that the Morgan Stanley

Trusts are or will be considered an “investment company” that is required to be registered under the Investment Company Act, which change or prospective change becomes effective or would become effective, as the case may be, on or after the date of this offering memorandum.

“Property trustee event” means the occurrence of certain events of bankruptcy or insolvency with respect to the property trustee or all or substantially all of its property if a successor property trustee has not been appointed within 90 days of the event.

“Regulatory event” means the determination by Morgan Stanley, based on the opinion of counsel experienced in such matters, who may be an employee of Morgan Stanley or any of its affiliates, that as a result of:

�	any amendment to, clarification of or change (including any announced prospective change) in applicable laws or regulations or official interpretations thereof or policies with respect thereto, or

�

AGREED AND ACCEPTED:		Name of Investor: Best Investment Corporation, a limited liability company incorporated in Beijing under the Chinese laws

Morgan Stanley, a Delaware corporation

By:	/s/ T.C. Kelleher	By:	/s/ Gao Xiqing
Name: Title:	T.C. Kelleher Chief Financial Officer	Name: Title:	Mr. Gao Xiqing Executive Director and President

		Address: Suite 936, No. 2 Building, No. 1 Complex, Nao Shi Kou Da Jie, Xicheng District, Beijing, P.R. China Contact Name: Mr. Gao Xiqing Telephone: (86-10) 5836 5880 Email Address: xqg@china-inv.cn Copies to: Contact Name: Hong Zhang Telephone: (86-10) 5836 5903 Email Address: zhanghong@china-inv.cn

By:	/s/ Lou Jiwei
Name:	Mr. Lou Jiwei
Title:	Chairman and CEO

Aggregate Stated Amount of Corporate Units to be issued by Morgan Stanley and each Morgan Stanley Trust	On each closing date contemplated in the Securities Purchase Agreement, Morgan Stanley and the Morgan Stanley Trusts will issue three series of Corporate Units. The stated amount of Corporate Units to be issued by Morgan Stanley and each Morgan Stanley Trust will be allocated among the trusts in equal thirds, adjusted as necessary such that the stated amount of Corporate Units issued by Morgan Stanley and each Morgan Stanley Trust will be an integral multiple of $1,000.
First Issue Date	December 28, 2007, or as soon as practicable thereafter.
Second Issue Date	If there is a second issue date of the Corporate Units, as contemplated by the Securities Purchase Agreement, Morgan Stanley and each Morgan Stanley Trust will issue additional Corporate Units in the amount specified in the Securities Purchase Agreement, with the stated amount of such additional Corporate Units allocated among the trusts in equal thirds, adjusted as necessary so that the stated amount of Corporate Units issued by each trust will be an integral multiple of $1,000.
Initial Interest Rate on Junior Subordinated Debentures and Initial Distribution Rate of the Related Trust Preferred Securities	6% per annum.
Rate of Contract Adjustment Payments on Stock Purchase Contracts	3% per annum.
Distribution Payment Dates	Distribution payments will accrue from the First Issue Date and be payable quarterly in arrears on each February 17, May 17, August 17 and November 17 occurring prior to and including the date of a successful remarketing, commencing February 17, 2008.
Remarketing Periods	Five consecutive business days beginning on the seventh business day prior to each of August 17, 2010, November 17, 2010, February 17, 2011, May 17, 2011 and August 17, 2011.
Reference Price	$48.07
Threshold Appreciation Price	The “threshold appreciation price” will equal 120% of the reference price.
Maturity of Junior Subordinated Debentures	February 17, 2042 (subject to change in connection with a remarketing of the related trust preferred securities or junior subordinated debentures).